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Summary 
 
Nematodes of the genus Ascaris are large gastrointestinal parasites. Ascaris 
lumbricoides infects ~1 billion people globally; causing malnutrition and 
general morbidity, and can block the gut or bile duct causing fatal 
complications. Ascaris suum is a parasite of pigs; in addition to its veterinary 
significance, it can occasionally be zoonotic, and is a good model of the human 
parasite. One of the main classes of drugs used to treat parasitic nematode 
infections are the cholinergic anthelmintics, such as levamisole and pyrantel, 
which act as agonists of nicotinic acetylcholine receptors at the nematode 
neuromuscular junction. The pharmacology of the native neuromuscular 
nAChRs from Ascaris suum has previously been well described, but most 
detailed studies of the molecular biology of nematode nAChRs have previously 
been confined to the model organism C. elegans. The aim of the work presented 
here was therefore to attempt to interpret the pharmacology of the nAChRs of 
Ascaris suum in terms of the underlying molecular biology. 
The genome of Brugia malayi, a parasite within the same phylogenetic clade as 
Ascaris suum, was searched for putative nAChR subunit sequences.The results 
of this search showed that parasites from this clade appear to have far fewer 
nAChR subunit genes than C. elegans, though three subunits known to be 
involved in levamisole sensitivity in C. elegans, unc-38, unc-29 and unc-63, 
were present and well conserved. Full-length sequences of unc-38 and unc-29 
were then amplified from Ascaris suum, though only a partial sequence of unc-
63 was obtained. An additional, novel nAChR subunit with no C. elegans 
homologue was also amplified from Ascaris suum. 
Antisera were raised against peptides from Ascaris suum UNC-38, UNC-29 and 
UNC-63, and were used to perform indirect immunofluorescent labelling of the 
nAChR subunits. All three subunits were shown to be present on the membrane 
of muscle cells from Ascaris suum, and UNC-38 and UNC-29 were shown to 
clearly co-localise. 
Expression of UNC-38 and UNC-29 in Xenopus oocytes yielded functional 
receptors which were characterised pharmacologically using two-electrode 
voltage-clamp electrophysiology. Both UNC-38 and UNC-29 were necessary to 
generate a functional receptor, which was sensitive to the agonists levamisole, 
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acetylcholine and nicotine, and the antagonist mecamylamine. Further 
experiments demonstrated that the pharmacology of the receptors could be 
changed by altering the stoichiometry, using different ratios of unc-38:unc-29 
RNA. Addition of more unc-38 produced a receptor more sensitive to nicotine 
and oxantel, but less sensitive to levamisole and insensitive to pyrantel. 
Addition of more unc-29 produced a receptor more sensitive to levamisole and 
pyrantel, but less sensitive to nicotine and insensitive to oxantel. The 
pharmacology of the receptors produced in this study by heterologous 
expression in oocytes resembled two distinct pharmacological subtypes of 
nAChR previously described from native Ascaris suum muscle cells. 
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Chapter 1: Introduction 
 1
 
 
1.1  Nematodes 
 
1.1.1 The diversity of nematodes 
The phylum nematoda is incredibly diverse, with estimates of number of 
species ranging from tens of thousands to several million (Lambshead 1993). 
Nematodes inhabit a diverse array of trophic niches, ranging from free-living 
bacteriovores found in soil and marine sediments, to parasites of plants, 
invertebrates and vertebrate animals (Baldwin et al., 2004; Blaxter et al., 1998; 
Lambshead, 1993). Despite superficial morphological similarities and a lack of 
fossil evidence, molecular analysis has greatly increased our understanding of 
nematode phylogeny (Blaxter et al., 1998; Conway-Morris, 1981). Analysis of 
small subunit ribosomal RNA sequences has produced a robust phylogenetic 
framework for the nematodes, resolved into five monophyletic clades (Blaxter 
et al., 1998; Dorris et al., 1999). A modified version of this accepted phylogeny 
is shown in Figure 1.1. Interestingly, the SSU rRNA phylogeny supports 
multiple origins of parasitism in nematodes: plant parasitism evolved 3 times, 
and animal parasitism arose independantly at least 6 times during the course of 
nematode evolution (Blaxter et al., 1998; Dorris et al., 1999).  
Clade I contains nematodes occupying a range of ecological niches: free-living, 
plant parasitic, the insect parasitic Mermithida, and the vertebrate parasite 
genera Trichinella and Trichuris (Blaxter et al., 1998; Dorris et al., 1999). 
Clade II is less well studied, but is known to contain both bacteriovores and 
plant parasites (Blaxter et al., 1998). Clade III is composed almost exclusively 
of animal parasites, of both invertebrates and vertebrates (Nadler et al., 2007). 
Basal members of this clade are often parasites of the arthropod gut, suggesting 
that perhaps this pre-adapted clade III nematodes to later become parasites of 
vertebrates (Dorris et al., 1999). Clade VI contains notable plant parasites such 
as Meloidogyne and Globodera; also represented in this clade are the animal-
parasitic Strongyloides (Blaxter et al., 1998; Dorris et al., 1999; Mitreva et al., 
2005). Clade V contains soil and sediment-dwelling groups alongside several 
vertebrate-parasitic taxa of medical and veterinary importance (Blaxter et al., 
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1998). The most notable member of clade V is perhaps the free-living model 
organism Caenorhabditis elegans, the first metazoan animal for which a 
complete genome sequence was published (Blaxter, 1998; 
C.elegans_Sequencing_Consortium, 1998).  
Since the completion of the C. elegans genome sequencing project, knowledge 
of the molecular biology of a diverse assemblage of nematodes has expanded: 
genome sequencing projects have been undertaken for other Caenorhabditis 
species, the plant parasite Meloidogyne, and the animal parasites Haemonchus 
contortus, Brugia malayi and Trichinella spiralis (Blaxter, 2003; Ghedin et al., 
2007; Mitreva et al., 2005; Mitreva & Jasmer, 2006). For numerous other 
nematodes, EST datasets are being generated (Parkinson et al., 2004; Wylie et 
al., 2004). 
In summary, the complexity of the phylum Nematoda is revealed both by 
disparate ecology and genetic diversity, and recent advances in gene sequencing 
and analysis have begun to reveal the similarities, and differences, between 
members of this diverse phylum. 
 3
 
 
Figure 1.1: The phylogeny of nematodes  
 
This diagram is taken from Mitreva et al., 2005. The five-clade phylogeny is 
based on SSU rRNA analysis (Blaxter et al., 1998; Dorris et al., 1999), and 
includes species for which EST datasets or genome sequence is available. The 
symbols to the left of each species indicate the trophic mode of the nematode, 
ie. which species are parasites of plants, humans or other animals, and which 
are free living bacteriovores. 
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1.1.2 Parasitic nematodes 
Many nematode parasites of vertebrates are of medical and veterinary 
importance as they adversely affect human health and animal welfare. There is 
palaentological evidence that the association between vertebrates and their 
nematode parasites is ancient; coprolites have revealed that dinosaurs in the 
Cretaceous period carried ascarid parasites whose eggs are very similar to those 
produced by extant Ascaris species (Poinar & Boucot, 2006). The nematode 
parasites of humans also have a long-established history, with pinworm eggs 
(Enterobius vermicularis) being found in human faecal material dating from 
10,000 years ago (Fry & Moore, 1969). The entire range of nematode  parasites 
are too numerous to describe, but summarised here are notable examples of the 
main types of parasitic nematodes which have an impact on human health. 
Soil transmitted helminths are gastrointestinal parasites prevalent in many 
tropical countries with poor sanitation; infection rates are estimated at 
approximately a billion people worldwide (Bethony et al., 2006; de Silva et al., 
2003; WHO, 2005). This diverse collection of parasites includes the large 
roundworm Ascaris lumbricoides, the whipworm Trichuris trichiura, and the 
hookworms Ancylostoma duodenale and Necator americanus; many individuals 
in developing countries may be chronically infected with all three types 
(Bethony et al., 2006). Although complications from such infections may 
directly cause mortality, the more widespread and insidious impact of these 
parasites is from long-term morbidity (Bethony et al., 2006; WHO, 2005). 
Anaemia, malnutrition, and impaired growth and cognitive development are 
common sequelae of heavy helminth infections of children living in poverty 
(Bethony et al., 2006; WHO, 2005). In addition to this, diseases such as 
HIV/AIDS and malaria are exacerbated by co-infection with nematode parasites 
(Fincham et al., 2003; Le Hesran et al., 2004).  
More obvious pathologies are produced by infection with a sub-group of clade 
III nematodes, the filariae. These parasites are transmitted as microfilarial 
larvae by intermediate arthropod hosts, usually biting mosquitoes or blackflies, 
and develop within the tissues of their human or animal host. Lymphatic 
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filariasis, caused mainly by Brugia malayi and Wuchereria bancrofti, occurs in 
~80 countries and infects ~120 million people (Wynd et al., 2007). 
Complications of this disease cause blocked and swollen lymphatic ducts, 
leading to fluid accumulation and grotesque swelling of the lower limbs or male 
genitalia (Partono, 1987). Infection with Onchocerca volvulus, the causative 
agent of "river blindness", causes visual impairment in approximately half a 
million people in sub-Saharan Africa (WHO, 1995). This symptom is caused by 
the inflammatory immune response to microfilarial larvae entering the 
conjunctiva and cornea of the eye (Hall & Pearlman, 1999). The microfilariae 
also migrate through the skin, causing chronic and disfiguring dermatitis (Kale, 
1998).  
Infection with parasitic nematodes overall causes a human disease burden 
second only to malaria in terms of disability-adjusted life years (Mathers et al., 
2007). In terms of the number of years through which people must live with the 
debilitating effects of chronic nematode infections, and indeed the number of 
years of life lost through acute infections, diseases caused by parasitic 
nematodes rival malaria and schistosomiasis in terms of their impact on human 
health in tropical countries (Mathers et al., 2007). 
 
1.1.3 Ascaris 
Nematodes of the genus Ascaris are large gastrointestinal parasites of pigs (A. 
suum) and humans (A. lumbricoides). Related ascarid parasites also occur in 
other mammals, birds and reptiles, and fossilised parasite eggs indicate that 
dinosaurs were also infected with an ascarid parasite, Ascarites (Poinar & 
Boucot, 2006).  
Ascaris lumbricoides is transmitted to humans from soil contaminated with 
infected faecal material, so has a high prevalence in areas with poor sanitation. 
It is estimated that approximately 1000 million people globally are infected 
with Ascaris (Bethony et al., 2006). After ingestion of embryonated eggs, the 
larvae hatch in the gut, penetrate the intestinal mucosa and migrate via the liver 
to the lungs. The pulmonary stage of Ascaris infection may give rise to 
associated symptoms such as pulmonary eosinophilia (Chitkara & Krishna, 
2006). The larvae ascend the respiratory tract and are swallowed, then 
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subsequently develop to adults within the intestines. The lifecycle of Ascaris is 
summarised in Figure 1.2. 
Considerable morbidity is associated with Ascaris infection, particularly in 
children; malnutrition leading to impaired development is a common 
consequence (Crompton, 1986; Hlaing, 1993). Pathologies arising from Ascaris 
infection include blockage of the pancreatic and biliary duct, and where a heavy 
worm burden is present intestinal occlusion may occur; such complications 
result in hospitalisation and may cause fatalities (Bahu, 2001; de Silva, 1997). 
The pig parasite Ascaris suum is considered a good experimental model of 
human ascariasis (Boes & Helwigh, 2000). There is also evidence of humans 
infected with Ascaris suum; microsatellite markers suggest that Ascaris 
populations have switched between porcine and human hosts several times 
during their recent evolution (Criscione et al., 2007). Ascariasis may primarily 
be a zoonosis in communities with no endemic Ascaris lumbricoides and which 
have close contact with swine harbouring Ascaris suum (Criscione et al., 2007; 
Nejsum et al., 2005). In addition to its role in human disease, Ascaris suum is 
studied as a helminth of veterinary significance. Infection of farmed pigs lowers 
productivity and has considerable economic consequences; losses of $155 
million per year due to Ascaris suum infections in US swine herds have been 
reported (Stewart & Hale, 1988).   
 
 
 
 
 7
 
 
Figure 1.1: The lifecycle of Ascaris spp. 
 
Ascaris suum and Ascaris lumbricoides are large gastrointestinal parasites of 
swine and humans respectively. The eggs are soil-transmitted, ie. expelled in 
faecal material and transmitted to a new host by ingestion of eggs. The infective 
larvae hatch in the gut and undergo a complicated migration via the 
bloodstream to the lungs, before re-entering the gut and developing to adults in 
the small intestine. 
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1.2 Anthelmintics 
1.2.1 Anthelmintics 
Since the 1970s, 3 classes of broad-spectrum anthelmintics have been used to 
treat nematode infestations of veterinary and medical significance: the 
benzimidazoles, the macrocyclic lactones (eg. avermectins), and the 
imidazothiazoles (eg. levamisole) (Burg et al., 1979; Thienpont et al., 1966).  
Benzimidazoles were originally used as antifungal agents; their mode of action 
is to prevent polymerisation of β-tubulin in the pathogenic organism (Allen & 
Gottlieb, 1970; Davidse & Flach, 1978). However, despite the continuing use of 
these compounds, resistance rapidly emerged in both fungi and nematodes, 
necessitating the development of alternative anthelmintics (Hastie & 
Georgopoulos, 1971; Theodorides et al., 1970). 
The macrocyclic lactones and the imidathiazoles both target cys-loop ligand-
gated ion channels of nematodes; they cause paralysis of the worm, which in 
the case of gastrointestinal nematodes leads to their expulsion from the gut. The 
macrocyclic lactones also have the advantage of acting on ion channels of 
arthropods, so are also effective against ectoparasites and insect disease vectors 
(Goudie et al., 1993; Mellin et al., 1983). The targets of the avermectins are 
post-synaptic ligand-gated chloride channels; initially this was thought to be 
mainly GABA receptors, but later studies discovered that the glutamate-gated 
chloride channels are the main target in nematodes (Holden-Dye & Walker, 
1990; Wolstenholme & Rogers, 2005; Yates et al., 2003; Yates & 
Wolstenholme, 2004). The avermectins bind with high affinity to nematode 
chloride channels and open them irreversibly, leading to an effective inhibition 
of muscle contraction and therefore a flaccid paralysis of the parasite 
(Wolstenholme & Rogers, 2005). 
The imidazothiazoles target excitatory nAChRs at the nematode neuromuscular 
junction, causing prolonged muscle contraction and a spastic paralysis in the 
nematode (Aceves et al., 1970). The effects of levamisole on nematode 
neuromuscular nAChRs are discussed further in section 1.4.1. 
More recently, two new classes of anthelmintic drugs have been developed, 
with the advantage of being effective against nematodes resistant to the other 
classes of anthelmintic: these are the cyclo-octodepsipeptide emodepside, and 
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the aminoacetonitrile derivatives (AADs) (Harder et al., 2003; Kaminsky et al., 
2008). Emodepside has been shown to bind to latrophilin and inhibit pharyngeal 
muscle in C. elegans, but its main mode of action is thought to be via calcium-
activated potassium channels, where it acts to cause paralysis (Guest et al., 
2007; Harder et al., 2005; Harder et al., 2003). The AADs, like the 
imidazothiazoles, target nematode nAChRs, but in the case of AADs, a 
different subtype of nAChR is targeted. This nAChR contains the subunit ACR-
23, belonging to a poorly-characterised but nematode-specific group of 
neuronal nAChR subunits (Kaminsky et al., 2008; Mongan et al., 1998; Yassin 
et al., 2001). The AAD compounds have been shown to be effective against 
levamisole-resistant nematodes, confirming that they target a different nAChR 
subtype (Kaminsky, Ducray et al. 2008). 
 
1.2.2 Resistance  
Drug resistance in nematodes is defined as occuring when a greater frequency 
of individuals in the parasite population are no longer affected by the usual 
efficacious dose of anthelmintic due to an inherited characteristic (Prichard et 
al., 1980). The main mechanisms by which resistance develops are changes in 
the drug target site or upregulation of mechanisms which detoxify or remove 
the drug (Wolstenholme et al., 2004). In a veterinary context, widespread and 
indiscriminate use of anthelmintics has led to selection for resistance alleles in 
the nematode parasites of a range of hosts. Drug resistance is a widespread 
problem in sheep and other small ruminants, and also occurs in cattle and 
horses (Jackson & Coop, 2000; Kuzmina & Kharchenko, 2008; Loveridge et 
al., 2003). Resistance has developed to all 3 of the most widely used 
anthelmintics, and in some cases, parasite populations may be resistant to all 3 
drug types, presenting serious problems for parasite control and animal welfare 
(Bartley et al., 2004; Coles et al., 1996). In a medical context, there have been 
reports of potential drug resistance in the causative agent of river blindness, 
Onchocerca volvulus (Awadzi et al., 2004). With the advent of mass 
chemotherapy programmes to treat parasitic diseases of humans, it is likely that 
more cases of drug resistance will emerge. 
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Benzimidazole resistance is probably the best understood in terms of the 
underlying mechanisms; its history as an antifungal agent, to which fungi could 
become resistant, set a precedent for this (Allen & Gottlieb, 1970; Theodorides 
et al., 1970). Mutations in β-tubulin which prevent the drug binding have been 
found in benzimidazole resistant Haemonchus contortus, Cooperia onchophera, 
and Teladorsagia circumcincta; this is therefore likely to be a major resistance 
mechanism (Kwa et al., 1994; Silvestre & Cabaret, 2002). However, it is worth 
noting that additional non-specific mechanisms such as upregulation of P-
glycoprotein efflux pumps could also contribute to benzimidazole resistance; 
this is also likely to be a factor in certain cases of avermectin resistance 
(Blackhall et al., 1998; Blackhall et al., 2008; Kerboeuf et al., 2003).  
Aside from the involvement of P-glycoproteins, no widespread mechanism of 
resistance to the avermectins has been clearly demonstrated. Mutations in 
glutamate-gated chloride channel genes confer reduced ivermectin sensitivity to 
C. elegans and to parasite glutamate-gated chloride channel genes expressed in 
the laboratory, but evidence of such mutations in field populations of parasites 
remains scarce (Dent et al., 2000; McCavera et al., 2007). 
Levamisole resistance in parasites remains equally hard to define on a 
molecular level, although numerous studies have shown that mutating certain 
nAChR subunit genes in C. elegans affect levamisole sensitivity (Culetto et al., 
2004; Fleming et al., 1997; Lewis et al., 1980). It has been shown that loss of a 
levamisole-sensitive nAChR subtype occurs in levamisole-resistant 
Oesophagostomum dentatum, but the genetic changes behind this remain 
unknown (Martin & Robertson, 2000; Robertson et al., 1999). A paucity of 
information regarding the molecular biology of levamisole-receptors in 
parasites has hindered the search for any potential target site mutations 
associated with resistance. 
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 1.3 Cys-loop ligand gated ion channels 
 
1.3.1 Diversity and general structure of cys-loop LGICs 
The cys-loop ligand gated ion channels are pentameric proteins; each subunit is 
composed of an N-terminal ligand binding domain, and 4 transmembrane 
regions which form the ion channel (Sine & Engel, 2006). The term "cys-loop" 
refers to a characteristic closed loop motif formed by a disulphide bond 
between 2 cysteine residues in the N-terminal part of the protein. The native 
ligand is usually a neurotransmitter, and ligand binding causes a conformational 
change which induces the channel to open (Lester et al., 2004). The second 
transmembrane regions line the ion channel pore, and charged residues in this 
region confer cation or anion selectivity (Galzi et al., 1992). The structure of 
the ligand binding domain has been well described, due to a resolved crystal 
structure of the acetylcholine binding protein from Lymnaea stagnalis (Brejc et 
al., 2002). This protein is soluble and lacks transmembrane domains, but has 
the pentameric conformation and ligand binding loops characteristic of the cys-
loop LGICs (Brejc et al., 2002). 
The cys-loop LGIC superfamily is notable for its diversity, and for the 
remarkable degree of conservation of the key motifs among different 
organisms. Identification of LGICs from prokaryotes suggest these are the 
evolutionary precursors of eukaryotic cys-loop LGICs; the original function of 
these channels is thought to be chemotaxis (Tasneem et al., 2005). A molecular 
clock approach (ie. analysis of mutation accumulation rates) dates the origin of 
the LGICs at approximately 2500 million years ago (Ortells & Lunt, 1995). 
Certain members of the cys-loop LGIC superfamily are conserved in both 
vertebrates and invertebrates, which implies they were present in the last 
bilaterian ancestor (Dent, 2006; Ortells & Lunt, 1995). These include the 
acetylcholine and serotonin gated cation channels, and the GABA and glycine 
gated anion channels (Ortells & Lunt, 1995). Subsequent to the evolutionary 
divergence of the different animal phyla, the cys-loop LGIC families underwent 
lineage-specific expansion events and losses resulting in the diversity of 
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channel genes present in extant taxa (Dent, 2006). Perhaps surprisingly, the 
vertebrates retain only a relatively small cys-loop LGIC family (Dent, 2006). In 
contrast, the nematode C. elegans possesses the largest described cys-loop 
LGIC gene family, with 102 members; a large sub-set of these genes form an 
"orphan group" for which no ligand or function has yet been identified (Brown 
et al., 2006; Jones & Sattelle, 2008). Invertebrates also possess acetylcholine 
and serotonin gated anion channels, glutamate-gated cys-loop ligand-gated 
anion channels (distinct from the vertebrate tetrameric glutamate receptors) and 
also excitatory GABA-gated cation channels (Beg & Jorgensen, 2003; Putrenko 
et al., 2005; Ranganathan et al., 2000; Yates & Wolstenholme, 2004). It has 
been proposed that animals with a very simple nervous system (such as the 302 
neurons of C. elegans) may utilize a large cys-loop LGIC family to enhance 
their neurotransmission repertoire; more complex neural circuits may reduce 
the need for such molecular diversity in signalling proteins (Littleton & 
Ganetzky, 2000).  
 
1.3.2 Nicotinic acetylcholine receptors 
 
Nicotinic acetylcholine receptors are the most well characterised of the cys-loop 
ligand-gated ion channels. Like all members of the LGICs, the nAChRs are 
pentameric, composed of five subunits arranged around the ion channel pore. 
Evidence for the pentameric nature of nAChRs was first provided by studies of 
material from the electric ray Torpedo marmorata, the electric organs of which 
are a rich source of nAChRs (Brisson & Unwin, 1985). Tubular crystals of 
nAChRs from Torpedo have provided the basis for many structural studies of 
nAChRs (Unwin, 1998; Unwin, 2005). Each subunit of the nAChR is composed 
of 3 distinct domains. The N-terminal region of the protein is extracellular and 
protrudes into the synaptic cleft; this is the ligand-binding domain, and also 
bears the cys-loop characteristic of this LGIC family (Arias, 1997). The 
transmembrane domain forms the ion channel and is composed of 4 membrane-
spanning components, TM1-TM4, believed to be hydrophobic alpha-helices. 
The ligand-binding and ion-channel domains and their role in nAChR function 
are described in more detail in sections 1.3.3 and 1.3.4. The cytoplasmic region, 
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particularly the long cytoplasmic loop between TM3 and TM4, bears numerous 
phosphorylation sites which play a role in modulating receptor sensitivity 
(Huganir & Greengard, 1990). The cytoplasmic region also interacts with 
proteins involved in nAChR clustering (Phillips et al., 1991). 
The general structure of the nAChR is shown in Figure 1.3. 
 
 
Figure 1.2: Structure of the nicotinic acetylcholine receptor  
 
This diagram is adapted from Brown et al. 2006.The nAChR is a pentamer 
composed of five subunits, though the structure is only shown here for one 
subunit. The N-terminal regions of the subunits are extracellular and form the 
acetylcholine binding sites, and also bear the cys-loop characteristic of this 
receptor family of ligand gated ion channels. The transmembrane domains, here 
labelled 1-4, form the ion channel, which opens as a result of conformational 
changes induced by ligand binding. 
 
 Na
+ Ca2+       K+
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1.3.3 nAChR subunit composition and stoichiometry 
 
Vertebrates possess 17 nAChR subunits, including α1-α10 (though α8 appears 
to be specific to birds, and α5 lacks the loop C tyrosine residue characteristic of 
α subunits described below, and in section 1.3.4), β1-β4, γ, δ, and ε (Millar & 
Gotti, 2008). The distinction between α and non-α subunits was initially based 
on the presence of two adjacent cysteine residues involved in ligand binding 
first described from the Torpedo α1 subunit cDNA (Noda et al., 1982). It 
should be noted that the presence of these two residues alone is not necessarily 
an indication that a subunit can form the principal components of a ligand 
binding site, and later work suggests that the definition of an α subunit should 
also include an important tyrosine residue, ie. the defining motif would be Y-X-
CC (Abramson & Taylor, 1990). The role of these and other amino acids in 
nAChR ligand binding is described further in section 1.3.3. 
Nicotinic acetylcholine receptors may be homomeric, composed of only one 
type of subunit, or heteromeric, composed of 2-4 different subunit types .The 
nAChR of the Torpedo electric organ has the same subunit composition as most 
vertebrate muscle nAChRs, being composed of two α1 subunits, and also a γ, δ 
and β1 subunit (Einarson et al., 1982; Raftery et al., 1976), though in 
mammalian muscle an ε subunit replaces γ soon after birth (Witzemann et al., 
1989). Homomeric receptors include human neuronal α7, and the avian subunit 
α8 (Couturier et al., 1990; Gerzanich et al., 1994; Peng et al., 1994). Most other 
receptors assemble from two or three different subunit types, and variations in 
subunit composition and stoichiometry can produce a diverse array of receptor 
subtypes with different calcium permeabilities and pharmacological properties 
(Millar & Gotti, 2008). An example of how changes to receptor stoichiometry 
can generate diversity in the pharmacology and channel properties of nAChRs 
is provided by α4β2 receptors, which are abundant in the mammalian brain. 
Receptors with the composition (α4)2(β2)3 have different agonist affinity than 
receptors with the (α4)3(β2)2 stoichiometry, and addition of a third type of 
subunit to give (for example) (α4)2(β2)2α5 further modifies receptor properties 
(Kuryatov et al., 2008; Moroni & Bermudez, 2006; Moroni et al., 2006). 
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1.3.4 The ligand binding domain of nAChRs 
 
Evidence that the extracellular N-terminal domain bears the nAChR ligand 
binding sites has been provided by photoaffinity labelling or radioisotope 
labelling of the binding sites using appropriately modified agonist or 
competitive antagonist compounds (Changeux et al., 1967; Chiara & Cohen, 
1997). The contribution of the labelled sites to ligand binding has also been 
confirmed by mutation of these candidate amino acids and electrophysiological 
characterisation of the resulting recombinant receptors (Galzi et al., 1990; 
Mishina et al., 1985; Sine et al., 1994). Though it is beyond the scope of this 
introduction to describe in detail the extensive body of work contributing to our 
knowledge of nAChR ligand binding, this has been comprehensively reviewed 
by Arias (Arias, 1997; Arias, 2000). Presented here is a summary of the nAChR 
components believed to make important contributions to agonist and non-
competitive antagonist binding; this is also shown in Figure 1.3.2.  
Initial photoaffinity labelling experiments showed that the α subunits were the 
primary contributor to ligand binding (Changeux et al., 1967). It has since been 
confirmed that several amino acids characteristic of α subunits play a key role 
in ligand binding: in the α1 subunit, these are Y190, C192, C193 and Y198, 
which comprise ligand binding loop C (Kao & Karlin, 1986; Mishina et al., 
1985; Sine et al., 1994). Two additional loops from the α subunits have also 
been found to contribute residues involved in ligand binding: loop A provides 
Y93 and loop B provides W149 in the Torpedo α1 subunit; these residues are 
also conserved in α7, occuring at positions 92 and 148 (Galzi et al., 1991a; 
Galzi et al., 1990; Galzi et al., 1991b). The aromatic groups provided by the 
ligand binding residues has been shown to be of particular importance when 
binding ligands with quaternary ammonium groups (Sine et al., 1994). 
Although the principal components of ligand binding are contributed by α 
subunits, additional components involved in ligand binding are provided by the 
adjacent subunit, so that the ligand binding site is actually located at the 
interface between subunits; in the absence of non-alpha subunits, the muscle α1 
subunit does not bind agonist or d-tubocurarine (Blount & Merlie, 1989; 
Kurosaki et al., 1987). In homomeric receptors these additional binding motifs 
are also present on the α subunit, but in heteromeric receptors they are provided 
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by non-α subunits. These ligand binding regions are termed loops D, E and F; 
loop D includes a tryptophan residue at position 55 of the vertebrate muscle γ 
subunit or position 57 of the δ subunit which is also conserved in the α7 
receptor at position 54, and has been labelled with both d-tubocurarine and 
nicotine (Chiara & Cohen, 1997; Chiara et al., 1998; Corringer et al., 1995). 
While conserved residues on the complementary binding loops may confer 
similarities in agonist and antagonist affinities, variations between subunits in 
the amino acids contributing to ligand binding can also lead to pharmacological 
differences. In the vertebrate muscle nAChR, the two binding sites in the same 
receptor have different properties, with the αγ binding site showing a low 
affinity for ACh but a high affinity for d-tubocurarine, and the αδ binding site 
having a higher affinity for ACh but a lower affinity for d-tubocurarine (Blount 
& Merlie, 1989; Pedersen & Cohen, 1990). An additional example of the 
pharmacological properties which may be confered on a receptor by the 
complementary binding components is the dependence of neonicotinoid 
insecticide sensitivity on  residues present in loop D and loop F (Shimomura et 
al., 2003). 
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Figure 1.3: The amino acid residues of the nAChR involved in agonist 
binding (Changeux & Taly, 2008) 
 
Diagram taken from Changeux & Taly, 2008, showing the residues involved in 
the binding of acetylcholine. This diagram depicts the ligand binding residues 
from the α1 and γ subunits from the electric organ of Torpedo californica 
.Principal binding loops A, B and C are present the α subunit, with 
complementary binding loops D, E and F contributed by the adjacent subunit. 
Evidence for the involvement of these residues in ACh binding has been 
provided by both biochemical labelling and mutagenesis studies. 
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 1.3.5 The nAChR ion channel 
 
On binding of ligands to the extracellular domain of the nAChR, the protein 
undergoes a conformational change which causes a rotational movement and 
consequently opens the ion channel (Sansom, 1995). This has been inferred 
from comparison of the structure of the Torpedo nAChR in the open and closed 
states, and the conformational change responsible for channel opening has also 
been modelled (Taly et al., 2005; Unwin, 1993; Unwin, 1995).  
The ion channel domain is formed from the transmembrane regions of the 
nAChR, and the second transmembrane region of each subunit forms the pore 
of the ion channel (Imoto et al., 1986). There is also evidence that residues at 
the N-terminal region of the first transmembrane domain may also contribute to 
formation of the channel pore (Zhang & Karlin, 1997). Most of the evidence 
supporting the involvement of these regions in ion channel function has been 
provided by selective mutation of the amino acids in these regions, then 
heterologous expression of the resulting subunits (Akabas et al., 1994; Mishina 
et al., 1985). The ion channel of the nAChR is permeable to cations, and this 
specificity is conferred by three rings of negatively charged amino acids present 
in all the constituent subunits (Corringer et al., 2000; Imoto et al., 1988). These 
rings are positioned at both ends of the second membrane-spanning region, and 
also at an intermediate position which is within the ion channel pore but below 
the hydrophobic alpha helix of the transmembrane region (Imoto et al., 1988). 
Figure 1.3.3 shows the positions of the rings of negatively charged residues in 
the homomeric α7 nAChR. It has also been demonstrated that these few amino 
acids are not only necessary but also sufficient to confer cation specificity to an 
ion channel; mutations at just these three charged amino acids in each subunit 
can convert a cation channel to an anion channel (Galzi et al., 1992). However, 
the channel conductance and relative calcium permeability of an nAChR are 
dependant on the properties of additional amino acids in the channel pore 
region (Fucile, 2004; Villarroel & Sakmann, 1992).  
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Figure 1.4: The ion channel of the nAChR  
 
Diagram taken from Corringer et al., 2000. This diagram shows the amino acids 
from the M2 domain of the homomeric α7 nAChR involved in formation of the 
ion channel pore. The external ring, intermediate ring and internal ring are 
composed of negatively charged residues present on all five subunits which 
confer cation specificity to the channel. Only M2 regions from 2 subunits have 
been shown for clarity; the other transmembrane regions have also been 
omitted, except to indicate where the extracellular end of M1 interacts with M2. 
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1.4 Nematode nAChRs 
 
1.4.1 Pharmacology of nematode neuromuscular nAChRs 
Much of the research investigating nematode nAChR pharmacology has been 
carried out using muscle tissue from Ascaris suum; the large size of the worm 
allows muscle strips and individual muscle cells to be removed with relative 
ease. The earliest studies were based primarily on muscle contraction assays in 
response to application of agonist and antagonist drugs (Baldwin & Moyle, 
1949). Ascaris muscle was shown to contract in response to both acetylcholine 
and nicotine, and inhibition of ACh-induced contractions could be 
accomplished by application of tubocurarine and mecamylamine; this provided 
direct evidence for a nAChR involved in Ascaris muscle contractions (Baldwin 
& Moyle, 1949; Natoff, 1969; Rozhkova et al., 1980). 
Electrophysiological techniques have also been widely used to study the 
pharmacology of native Ascaris nAChRs; these recordings utilize extrasynaptic 
receptors present on the muscle bag cell (Colquhoun et al., 1991; Martin, 1993). 
Such studies confirmed the primarily nicotinic nature of the ACh response: 
ACh and nicotine produced dose-dependant depolarisation of the muscle cell, 
while muscarinic agonists showed little effect (Colquhoun et al., 1991). 
Mecamylamine was again shown to be a potent antagonist at <1µM 
concentration, whereas atropine was 100-fold less effective at reducing the ACh 
response (Colquhoun et al., 1991). Attempts to further characterise the Ascaris 
nAChRs using antagonists selective for different vertebrate nAChR subtypes 
proved difficult; for example curare and pancuronium had similar efficacy as 
antagonists of Ascaris nAChRs, though these compounds have very different 
potencies as antagonists of vertebrate neuromuscular nAChRs (Buckett, 1968; 
Colquhoun et al., 1991).  
The use of cholinergic anthelmintic compounds such as morantel, oxantel, 
pyrantel and levamisole have been perhaps more useful in elucidating the 
pharmacology of nematode nAChRs. These compounds are potent agonists of 
nematode neuromuscular nAChRs; depolarisation of muscle cells causing 
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muscle contraction and spastic paralysis underlies their efficacy as anthelmintic 
agents (Aceves et al., 1970). In addition to this, their selectivity for nematode 
rather than vertebrate nAChRs produces minimal toxicity when used as 
therapeutic drugs for the treatment of livestock and humans (Aubry et al., 1970; 
Eyre, 1970). Electrophysiological recordings of Ascaris muscle cell responses 
to the cholinergic anthelminics were first performed by Harrow and Gration 
(1985). This demonstrated dose-dependant increases in cation conductance in 
response to levamisole, with the EC50 for levamisole being 5-10 fold lower than 
for ACh (dependant on method of drug application). Pyrantel and morantel 
were shown to be even more potent agonists at low concentrations (10nM-
10µM) but gave a bell-shaped dose response curve, indicating either 
desensitization or open channel block at high concentrations (Harrow & 
Gration, 1985). 
Patch-clamp techniques and single-channel recordings have confirmed the 
mode of action of the cholinergic anthelmintics, and allowed different nAChR 
subtypes present on Ascaris muscle to be characterised; 3 nAChR subtypes with 
different conductances and mean open times have been described (Qian et al., 
2006; Robertson & Martin, 1993; Robertson et al., 1994). These can be 
distinguished pharmacologically by their relative sensitivities to selective 
agonists and antagonists, and their properties are summarised in Figure 1.4. The 
large conductance channel is the B-subtype, most sensitive to bephenium, and 
can be selectively antagonised using 2-deoxy-paraherquamide. The small 
conductance channel is the N-subtype, sensitive to agonists nicotine, 
methyridine and oxantel, and relatively insensitive to antagonist 
paraherquamide. The channel of medium conductance is the L-subtype 
receptor, activated by the cholinergic anthelmintics levamisole and pyrantel, 
and sensitive to the antagonist paraherquamide (Levandoski et al., 2005; Martin 
et al., 2003; Martin et al., 2004; Qian et al., 2006; Robertson et al., 2002). It 
has been reported that levamisole and pyrantel resistance in the pig parasite 
Oesophagostomum dentatum may result from loss of the relevant receptor 
subtype (Robertson et al., 1999; Robertson et al., 2000). The finding that 
oxantel is selective for a different nAChR subtype than levamisole and pyrantel 
has important implications for the therapeutic use of these compounds; it is 
likely that nematodes resistant to one type of cholinergic anthelmintic may still 
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respond to another, provided it targets a pharmacologically distinct type of 
nAChR (Martin et al., 2004). 
 
 
 
Figure 1.5: The nAChR subtypes present on Ascaris muscle cells  
 
This diagram is taken from Qian et al., 2006. Single channel recordings from 
the muscle cells of Ascaris suum have demonstrated 3 distinct populations of 
nAChRs. These channels have different conductances and mean open times, 
and different pharmacological profiles. 
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1.4.2 Molecular biology of nematode nAChRs 
 
Although the parasite Ascaris suum has been the main focus of studies on 
nematode nAChR pharmacology, the majority of work on the molecular 
biology of nematode nAChRs has been confined to C. elegans. The main 
reasons for this are the highly complete and well annotated nature of the C. 
elegans genome sequence, and the ease with which mutants can be made and 
maintained in the laboratory.  
Interest in C. elegans nAChR genes began when it was discovered that certain 
levamisole-resistant C. elegans mutants had mutations in genes encoding 
nAChR subunits (Lewis et al., 1980). Since then, the nAChR gene family has 
been investigated in depth, and it has been found that C. elegans has the largest 
known nAChR gene family with ~30 subunits (Brown et al., 2006; Jones & 
Sattelle, 2004). A tree of sequence similarity for the C. elegans nAChR gene 
family is shown in Figure 1.4.2. The nAChR genes of C. elegans can be divided 
into several sub-groups, based on sequence similarity. The acr-16 group is 
named after the best characterised member of this group, acr-16, which encodes 
a homomeric, levamisole-insensitive receptor present at the C. elegans 
neuromuscular junction (Mongan et al., 2002; Raymond et al., 2000; 
Touroutine et al., 2005). The deg-3 group is nematode-specific and believed to 
encode mainly neuronal receptors; this group is of interest as it contains acr-23, 
the product of which is targeted by the new AAD anthelmintic compounds 
(Kaminsky et al., 2008). The acr-8 group is less well characterised, but contains 
lev-8 (also called acr-13), a nAChR subunit gene which is known to confer 
reduced sensitivity to levamisole when mutated (Towers et al., 2005).  
The groups of most relevance to the work presented here are the unc-38 group 
and the unc-29 group. The unc-38 group contains unc-38 and unc-63, which 
encode alpha subunits of the levamisole-sensitive nAChR at the C. elegans 
neuromuscular junction (Culetto et al., 2004; Fleming et al., 1997). The unc-29 
group contains unc-29 and lev-1, which encode non-alpha subunits present in 
the same receptor type (Ballivet et al., 1996; Fleming et al., 1997). Mutations in 
these subunits all reduce levamisole sensitivity, and heterologous expression of 
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unc-38, unc-29 and lev-1 produces a levamsiole-sensitive nAChR (Fleming et 
al., 1997).  
Prior to the start of the work presented in this thesis, it had been shown that 
several parasitic nematodes had mRNA transcripts encoding putative 
homologues of unc-38 (Ajuh & Egwang, 1994; Hoekstra et al., 1997; Wiley et 
al., 1996). A review of potential nAChR sequences present in parasitic 
nematode EST libraries has yielded further putative homologues of C. elegans 
nAChR subunit genes; however, the localisation and functional significance of 
such gene products remains almost entirely unknown (Brown et al., 2006). A 
more recent study which identified and amplified several nAChR genes from 
the canine hookworm Ancylostoma caninum has provided the first evidence of 
changes in nAChR subunit expression in an anthelmintic resistant population of 
parasites. McCarthy and colleagues have recently demonstrated significantly 
lower levels of mRNA encoding the nAChR subunits unc-38, unc-29 and unc-
63 in hookworms which were highly resistant to pyrantel (Kopp et al., 2008). 
This provided the first direct evidence for the role of these nAChR subunits in 
determining cholinergic anthelmintic sensitivity in a parasitic species. 
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Figure 1.6: The nAChR gene family of C. elegans  
 
This diagram is taken from Brown et al. 2006. The cys-loop ligand-gated ion-
channel gene family of C. elegans contains ~100 genes, of which ~30 encode 
putative nAChRs. The nAChRs are here shown grouped by sequence similarity 
(coloured boxes), and have been aligned with the vertebrate nAChR sequences. 
Also shown are other cys-loop LGIC sequences from C. elegans, many of 
which are "orphans" for which no ligand has yet been identified. 
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1.5 Aims and Objectives 
 
The pharmacology of the native nAChRs present in muscle membrane from 
Ascaris suum has been well described, but most work on the molecular biology 
of nematode nAChRs has been performed using the model nematode C. elegans 
(Jones & Sattelle, 2004; Qian et al., 2006). The few studies which have 
investigated the molecular biology of nAChRs in parasites have utilised species 
in the same phylogenetic clade as C. elegans (Kopp et al., 2008). 
The aim of this project was to identify the nAChR subunits from Ascaris suum 
which formed the levamisole-sensitive nAChR, in order to understand the 
described pharmacology of the native nAChR in terms of the underlying 
molecular biology. The initial stage of the project aimed to identify which 
nAChR subunits were likely to be present by searching the genome of a related 
nematode, Brugia malayi, then to amplify subunits with a putative role in the 
levamisole receptor from Ascaris suum. 
The next objective was to raise antisera for immunofluorescent labelling, in 
order to ascertain whether the nAChR subunits were present on the Ascaris 
suum muscle membrane. The final aim of the project was to produce 
recombinant receptors in a heterologous expression system using the Ascaris 
nAChR subunit cDNA, to allow the pharmacology of the nAChRs to be 
characterised. 
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Chapter 2: Methods and Materials 
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2.1 Materials 
2.1.1 Nematode tissue 
The nematode tissue used in the initial stages of this project was kindly 
supplied by Professor Richard Martin and Dr. Alan Robertson of Iowa State 
University Veterinary College. Heads and muscle strips from freshly collected 
Ascaris suum adults were sent to the University of Bath packaged in dry ice. 
Upon arrival at the laboratory, the nematode tissue was stored at -80˚C to 
prevent RNA degradation. 
Live specimens of Ascaris suum, and Ascaris suum eggs, were kindly supplied 
by Emma Kidd and Professor Aaron Maule of Queen's University Belfast. 
These were sent to the University of Bath in Ascaris Ringer Solution (ARS) at 
ambient temperature. Upon arrival in the laboratory, eggs were aliquoted into 
2ml cryo-vial tubes and snap frozen then stored in liquid nitrogen. Live adult 
Ascaris suum were maintained in the laboratory for 2-3 days in a 5 litre plastic 
beaker containing 2-3 litres of ARS, kept in a 37˚C incubator with daily 
changes of solution. 
 
Table 2.1:  Composition of Ascaris ringer solution 
 
 
Ascaris Ringer Solution 
4 mM NaCl 
5.9 mM CaCl2
4.9 mM MgCl2
5 mM C4H11NO3/Tris 
125 mM NaC2H3O2
24.5 mM KCl 
pH 7.4 
 
 
2.1.2 Xenopus laevis oocytes. 
Defolliculated Xenopus laevis oocytes were obtained from Ecocyte 
Biosciences, Germany.  
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Table 2.2: Plasmids 
 
Plasmid 
 
Description and use Supplier 
pGEM®-T Easy Ampr, 3kb 
Used in initial cloning of gel-purified PCR products 
 
Promega 
pT7TS Ampr, modified pGEM®-4Z (Promega) containing 
UTR regions of Xenopus β-globin to enhance 
expression in Xenopus oocytes 
Addgene 
(original 
vector from 
Paul Krieg) 
 
 
Table 2.3: Enzymes 
 
Enzyme 
 
Reaction Buffer (10x) Supplier 
AffinityScriptTM
reverse transcriptase 
 
AffinityScriptTM RT buffer: 
50mM Tris-HCl (pH 8.3) 
750mM KCl 
30mM MgCl2
 
Stratagene 
Mango Taq 
DNA polymerase 
 
NH4 based buffer containing  
2mM MgCl2 and inert dyes 
Bioline 
Taq DNA polymerase 
 
PCR reaction buffer containing 
1.5mM MgCl2 
 
Roche 
Expand High Fidelity 
PCR system 
 
Expand High Fidelity reaction 
buffer containing 1.5mM 
MgCl2
Roche 
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T4 DNA ligase 
 
Ligase buffer: 
30mM Tris-HCl (pH 7.8) 
10mM MgCl2 
10mM DTT 
1mM ATP 
Promega 
T4 DNA ligase 
 
T4 DNA Ligase buffer: 
50mM Tris-HCl 
10mM MgCl2 
10mM DTT 
1mM ATP 
pH 7.5 
New England 
Biolabs 
BglII 
 
NEB Buffer 3: 
100mM NaCl 
 50mM Tris-HCl 
 10mM MgCl2
 1mM DTT 
 pH 7.9 
New England 
Biolabs 
 
EcoRI 
 
NEB Buffer U: 
100mM Tris-HCl 
50mM NaCl 
10mM MgCl2 
0.025 % Triton X-100
pH 7.5 
New England 
Biolabs 
SacI  
 
NEB Buffer 1: 
10mM Bis Tris Propane-HCl 
10mM MgCl2
1mM dithiotheitol 
pH 7.0 
New England 
Biolabs 
SpeI NEB Buffer 2 (as above) 
 
New England 
Biolabs 
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2.1.5 Chemicals and reagants 
Unless otherwise specified, all chemicals and general laboratory reagents were 
of molecular biology grade, and were purchased from Sigma-Aldrich, UK. 
 
2.2 Bioinformatics 
 
2.2.1 Reciprocal BLAST searches 
Sequences for the protein-coding regions of all the described C. elegans nAChR 
subunit genes (Jones & Sattelle, 2004) were obtained from the NCBI database 
(http://www.ncbi.nlm.nih.gov/). These sequences were then used to perform  
searches of the genome sequence of Brugia malayi  
(http://www.tigr.org/tdb/e2k1/bma1/) using the TBLASTN algorithm. This 
algorithm compares translated sequences at the amino acid level rather than 
making comparisons at the nucleotide level, so is more likely to identify 
homologous sequences from species which might have different codon usage. 
The closest match to the C. elegans query sequence found in the Brugia malayi 
genome was then used to perform a reciprocal TBLASTN search of the NCBI 
sequence database http://www.ncbi.nlm.nih.gov/BLAST). If this search 
identified the Brugia malayi sequence as most similar to the C. elegans nAChR 
subunit sequence used as the original query, the sequence was identified as 
genuinely homologous to this C. elegans nAChR subunit. This search strategy 
was then repeated to identify the nAChR subunit genes of another parasitic 
nematode, Trichinella spiralis. The Trichinella spiralis genome has been 
sequenced by the Washington University Genome Sequencing Centre 
(http://genome.wustl.edu/tools/blast/).  
 
2.2.2 Sequence alignments and tree construction 
When all putative nAChR sequences had been obtained from the parasite 
genomes, they were named according to their putative identity and listed along 
with their C. elegans homologues in a WordPad text document. This format is 
necessary to upload the sequences to the alignment program. The sequences 
were uploaded to ClustalX (version 1.83) and a complete alignment was 
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performed; the ClustalX program was also used to produce a boot-strapped 
neighbour-joined tree from the alignment. The tree of sequence similarity was 
viewed using TreeView (version 1.6.6). 
 
2.3 PCR and Cloning Methods 
2.3.1 Primer Design 
The NCBI database (http://www.ncbi.nih.gov/ ) was searched for nicotinic 
acetylcholine receptor subunit sequences from Ascaris spp. One partial 
sequence was present in the database, with accession number AJ011382; this 
corresponds to an alpha subunit and putative unc-38 homologue. The Ascaris 
suum EST database (http://zeldia.cap.ed.ac.uk/ncbi_blast.html ) was searched 
for sequences showing similarity to C. elegans nicotinic acetylcholine receptor 
subunits. Three such sequences were found, but upon translation and sequence 
comparison in all reading frames, two of these (ASC25431 and ASC07050_1) 
were found to contain non-coding regions with many stop codons, so were 
considered unlikely to encode nAChR subunits. One of the sequences from the 
EST database, ASC19452_1, was successfully translated and appeared to 
encode a putative nAChR subunit. Specific primers were therefore designed to 
amplify the AJ011382 and ASC19452_1 sequences. Further degenerate primers 
were designed to amplify additional nAChR subunits using the UNC-29 and 
UNC-63 nAChR sequences from C. elegans and Brugia malayi, based on 
conserved amino acids. This process is described more fully in section 3.3. 
 
2.3.2 RNA extraction 
All equipment used for RNA work was rendered RNase free before use. 
Pipettes, glassware and surfaces were treated with RNase away reagent (Fluka); 
plastic tubes, pipette tips and distilled water were treated with diethyl 
pyrocarbonate then autoclaved. 
RNA was extracted from the nematode tissue using Trizol® reagent 
(Invitrogen). The tissue was ground up using a cooled pestle and mortar and 1-
4ml Trizol® was added (volume depending on sample size). The Trizol® and 
nematode tissue were mixed further in a homogeniser, then decanted into 1.5ml 
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microcentrifuge tubes. The homogenate was centrifuged at 12000 x g at 4˚C for 
10 minutes to remove insoluble material, particularly protein from muscle strip 
samples. The supernatant was transferred to clean eppendorf tubes, then 0.2ml 
chloroform was added per 1ml of Trizol® used in the initial extraction. The 
tubes were shaken and incubated at ~20˚C for 2 minutes, then centrifuged at 
12000 x g at 4˚C for 10 minutes to separate the lower organic phase containing 
DNA and protein from the upper aqueous phase containing the RNA. The 
aqueous phase was transferred to a clean tube and mixed with isopropanol 
(0.5ml per 1ml Trizol® used initially) to precipitate the RNA. After incubation 
at ~20˚C for 10 minutes, the precipitated RNA was collected into a pellet by 
centrifugation at 12000 x g and 4˚C for 10 minutes. The supernatant was 
discarded, and the RNA pellet washed by resuspension in ethanol (1ml ethanol 
per 1ml Trizol® used initially). The RNA was again collected by centrifugation, 
at 7500 x g and 4˚C for 5 minutes. The RNA was air dried for ~5 minutes, then 
dissolved in 10-40µl RNase free water. 
The RNA was quantified and the purity checked by measuring the absorbance 
of a 1/100 dilution at 280nm and 260nm using a spectrophotometer. An 
A260/A280 ratio of ~1.8 indicated a pure RNA preparation. The amount of 
RNA was calculated by: 
 A260 x dilution factor x 40 = amount of RNA in µg/ml. 
 
2.3.3 Reverse Transcription 
The mRNA was reverse transcribed into cDNA using AffinityScript® reverse 
transcriptase (Stratagene). The following components were added to an RNase-
free 0.5ml tube:  
3µl  oligo(dT) primer (100ng/µl) 
~200ng total RNA (~1ng mRNA) 
RNase-free water to 14.2µl 
The reaction was heated to 65˚C for 5 minutes then slowly cooled to ~20˚C to 
allow (Bektesh et al., 1988)primer annealing.  
The following components were added to the reaction: 
2µl AffinityScript® 10x buffer 
2µl DTT 
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1µl AffinityScript® RT (50U/µl)  
0.8µl 100mM dNTPs 
The reaction incubated at 42˚C for 1 hour. After this time the reaction was 
stopped by incubation at 70˚C for 15 minutes.  
 
2.3.4 PCR 
All initial PCR reactions were carried out using Mango-Taq DNA polymerase 
(Bioline); this preparation contains loading dyes for electrophoresis in the 
buffer component. 
 50µl reactions were assembled as follows: 
5µl 10x Mango-Taq reaction buffer 
2.5µl MgCl2 (50mM) 
1µl Mango-Taq DNA polymerase (1U/µl) 
1µl dNTP mix (100mM) 
1µl cDNA template 
1µl forward primer (final concentration10 pmol specific primer, 100 pmol 
degenerate primer) 
1µl reverse primer (final concentration10 pmol specific primer, 100 pmol 
degenerate primer) 
37.5µl dd.H2O 
 
PCR conditions used with specific primers were as follows: 
2 minutes at 95˚C initial denaturation step 
35 cycles of: 
1 minute denaturation step at 95˚C 
1 minute primer annealing step at 2-5˚C below primer melting temperature 
1-2 minutes extension step at 72˚C (~1 minute per kilobase of product) 
Then a 5 minute extension step at 72˚C, followed by cooling to 16˚C, 
maintained until the programme was stopped and the reactions removed from 
the thermal cycler. 
 
PCR conditions used with degenerate primers were as follows: 
2 minutes at 95˚C initial denaturation step  
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10 cycles of: 
1 minute denaturation step at 95˚C 
1 minute primer annealing step at 3˚C above primer melting temperature, 
dropping -0.5˚C with each subsequent cycle 
1-2 minutes extension step at 72˚C (~1 minute per kilobase of product) 
30 cycles of: 
1 minute denaturation step at 95˚C 
1 minute primer annealing step at 2˚C below lower primer melting temperature 
1-2 minutes extension step at 72˚C (~1 minute per kilobase of product) 
Then a 5 minute extension step at 72˚C, followed by cooling to 16˚C, 
maintained until the programme was stopped and the reactions removed from 
the thermal cycler. A list of primers used for PCR is given in appendix i. 
When problems arose due to low expression levels or non-specific 
amplification, primer pairs internal to the original pair were designed, to carry 
out nested PCR and reamplify the products of the original PCR reaction. 
 
2.2.5  5’ and 3’ RACE 
When a specific partial sequence coding for a nAChR subunit had been 
obtained, 5’ and 3’ RACE (rapid amplification of cDNA ends) was carried out 
to obtain full length nAChR subunit sequences. 5’ RACE used a forward primer 
specific to the splice leader sequence SL1 known to precede most nematode 
coding sequences (Bektesh et al., 1988), and a reverse primer complementary to 
the nAChR partial sequence. 3’ RACE used a reverse primer complementary to 
a known anchor sequence added to the poly-A 3’ end of the mRNA during the 
reverse transcription, and a forward primer specific to the partial nAChR 
sequence. 
 
2.2.6 Agarose gel electrophoresis 
1% w/v gels were made from agarose dissolved in TBE buffer (see appendix i 
for buffer compositions). The mixture was microwaved until the agarose had 
dissolved, then allowed to cool to ~40˚C before addition of ethidium bromide to 
a final concentration of 0.5µg/ml. The gel was poured and allowed to solidify, 
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placed in an electrophoresis tank containing TBE buffer, then 20µl samples of 
PCR product and 100bp molecular weight markers (Promega) mixed with 5µl 
6x loading dye (Promega) were loaded. A current of 50-100mA was applied, 
and separation of the DNA by molecular weight tracked by migration of the 
loading dyes down the gel. 
 
2.3.7 Gel extraction 
If PCR products of the correct size were observed on the agarose gel, they were 
carefully excised with a clean razor blade, and the DNA extracted using a gel 
extraction kit (Qiagen). The gel slice was dissolved in 3 volumes of buffer to 1 
volume of gel by incubation at 50˚C for ~10 minutes. 1 volume of isopropanol 
to 1 volume of gel was added, then the mixture was applied to a DNA binding 
spin column and centrifuged at 13000 x g for 1 minute. The bound DNA on the 
spin column was then washed with 750µl ethanol-based buffer and 
subsequently dried by further centrifugations for 1 minute at 13000 x g. 30µl 
nuclease-free d.H2O was applied to the spin column, and the eluted DNA 
collected by a final centrifugation step at 13000 x g for 1 minute. 
 
2.3.8 Ligation reactions 
The gel extracted DNA was then ligated into pGEM-T Easy vector (Promega). 
Ligation reactions were assembled as follows: 
5µl 2x Rapid Ligation Buffer 
1µl pGEM-T Easy vector (50ng) 
3µl gel-extracted DNA 
1µl T4 DNA ligase (3U/µl) 
 The reactions were incubated for either 1 hour at room temperature or 
overnight at 4˚C. 
 
2.3.9 Preparation of competent cells 
A scraping of cells from a permanent culture of stock XL1 blue strain E.coli 
was inoculated into 100ml of LB broth in a 1 litre conical flask and incubated at 
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37˚C with moderate agitation for ~3 hours until the OD600 reached ~0.3 
(indicating that the number of viable cells < 108/ml). 
The culture was transferred to sterile 50ml tubes and cooled on ice for 10 
minutes, then centrifuged at 2700 x g at 4˚C for 10 minutes. The supernatant 
was discarded and the tube inverted to remove any remaining media from pellet 
of cells. The bacterial cells were resuspended in 30 ml of 80mM MgCl2-20mM 
CaCl2 solution which had previously been cooled on ice, then collected by a 
further centrifugation at 2700 x g at 4˚C for 10 minutes. After again discarding 
the supernatant and draining by inversion of the tube, the cells were 
resuspended in 2ml 0.1M CaCl2 (cooled on ice) per 50ml of original culture. 
Glycerol was added as a cryoprotectant (15-25% by volume) then the 
competent cells were dispensed into 200µl aliquots and snap-frozen in liquid N2 
prior to storage at -80˚C. 
 
2.3.10 Transformation of competent cells 
An aliquot of competent cells was thawed on ice. 200µl cells were added to the 
DNA insert/vector product of the ligation reaction, then left on ice for 30 
minutes. The cells were heat-shocked at 42˚C for 5 minutes, then added to 1ml 
of LB medium and incubated at 37˚C for 1 hour. LB/ampicillin agar plates were 
spread with 10µl IPTG (20%w/v) and 50µl X-Gal (2%, Promega), which was 
left to absorb at 37˚C for 1 hour. The transformed cells were collected by 
centrifugation (13000 x g for 1 minute), resuspended in residual media, then 
spread onto the prepared agar plates. The plates were incubated overnight at 
37˚C.  
Colonies containing recombinant plasmids with the DNA insert of interest were 
white in colour; these were used to inoculate LB/ampicillin broth and cultured 
overnight at 37˚C. 
 
2.3.11 Plasmid extraction and digest 
Plasmids were extracted from overnight cultures of transformed E. coli using 
the GenElute Plasmid Miniprep Kit (Sigma-Aldrich). 1.5ml of overnight culture 
was centrifuged at 13000 x g for 1 minute. The cells were resuspended in 200µl 
resuspension solution, then lysed by addition of 200µl alkaline-SDS lysis 
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buffer. After 5 minutes, 350µl high salt neutralisation/binding buffer was 
added, then the cell debris removed by centrifugation at 13000 x g for 10 
minutes. The supernatant (containing plasmids) was added to a DNA binding 
spin column (silica membrane which binds DNA in the presence of high salt 
concentrations, prepared according to the manufacturer’s instructions) and 
centrifuged for 1 minute at 13000 x g. The DNA bound to the spin column was 
then washed by addition of 750µl ethanol-based wash solution and 
centrifugation at 13000 x g for 1 minute; an additional centrifugation step was 
then performed for the same time and speed to remove all traces of wash 
solution from the spin column. The spin column was transferred to a clean 
collection tube, and the DNA eluted in 100µl nuclease-free dd.H2O. 
To confirm the presence of an insert in the extracted plasmids, a restriction 
enzyme digest was performed, using the enzyme EcoR1, as the vector used has 
restriction sites for this enzyme at either side of the insert site. Reactions were 
assembled as follows: 
5µl buffer (x10) 
1-5µl plasmid preparation 
0.2µl BSA 
0.5µl enzyme 
dd.H2O to 20µl 
The reactions were incubated at 37˚C for 1-4 hours, then 5µl loading buffer was 
added and the sample separated by agarose gel electrophoresis. If a DNA insert 
band corresponding to the size of the initial PCR product could be seen, the 
plasmid preparation was sent for sequencing, using M13 forward and reverse 
sequencing primers. A BLAST search was then performed to compare the 
resulting sequence with those in the NCBI database 
(http://www.ncbi.nih.gov/BLAST), to determine whether the cDNA sequence 
which had been amplified and cloned coded for a nicotinic acetylcholine 
receptor subunit.  
 
2.3.12 Proof -reading and sequence deposition 
Following successful amplification and cloning of a complete nAChR subunit 
sequence, the PCR reaction was repeated using new specific primers and the 
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Expand High Fidelity PCR system (Roche) to ensure the accuracy of the 
sequence amplification. The PCR product was then cloned as described 
previously, and plasmid from 3 or 4 separate clones was sequenced to ensure 
consensus. The sequences were then deposited in the NCBI database, and 
assigned accession numbers. 
 
2.3.13 Sub-cloning into expression vector pT7TS 
The pT7TS plasmid is an expression vector optimised for Xenopus oocyte 
expression by the insertion of the Xenopus β-globin 5' and 3' UTR sequence. 
This plasmid originated in the laboratory of Paul Krieg, University of Texas, 
and can be obtained from Addgene (plasmid 17091).  
The sequences of Ascaris suum unc-38 and unc-29 were analysed using 
software from  Biology Workbench 3.2 (http://seqtool.sdsc.edu/CGI/BW.cgi) to 
ensure that the restriction sites needed for sub-cloning into pT7TS, BglII and 
SpeI, were not present in the cDNA sequences. Primers were designed to 
amplify the full-length nAChR subunit cDNAs and add the appropriate 
restriction sites to the ends of the sequences; a full list of primers used is given 
in Appendix i. PCR was performed as described in section 2.2.4, using 1µl of 
pGEM-T Easy plasmid containing the nAChR subunit sequence as template. 
The PCR product was then cloned into pGEM-T Easy as described in sections 
2.2.10 and 2.2.11. 
1-3 µg of both the pGEM-T Easy plasmids containing the nAChR cDNAs plus 
restriction sites, and the pT7TS vector, were digested using the restriction 
enzymes BglII and SpeI as described on the New England Biolabs double-
digest finder website  
(http://www.neb.com/nebecomm/DoubleDigestCalculator.asp). Both the 
digested vector and nAChR sequences were purified by agarose gel 
electrophoresis (section 2.2.6). Both the plasmid and the insert were quantified 
by obtaining the A260 value using a spectrophotometer, then they were ligated 
together in a 1:3 vector:insert ratio using New England Biolabs T4 DNA ligase 
as described in the manufacturer's instructions. Competent cells were 
transformed using the product of the ligation reaction, then plated out and 
colonies picked and grown overnight as described in section 2.2.10. Plasmids 
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were purified (section 2.2.11) and sequenced to ensure that the pT7TS plasmids 
now contained the Ascaris suum unc-38 and unc-29 sequences. 
 
2.3.14 Real-time PCR 
Primers were designed to amplify ~200bp regions of the N-terminal regions of 
the Ascaris suum nAChR subunits unc-38, unc-29 and unc-63. An additional 
primer set was designed to amplify a region of similsr length from the Ascaris 
suum β-tubulin sequence obtained from the GenBank database (accession 
number FE918860). All primers had a similar length, GC content and melting 
temperature, and the primer sequences are listed in Appendix i. RNA was 
extracted from Ascaris heads and body wall sections as described in section 
2.3.2. Reverse transcription reactions were set up as described in section 2.3.3, 
ensuring that all reactions contained the same amount of RNA. The primers and 
cDNA were first tested by ordinary PCR, using the same reaction conditions 
which would be used for real-time PCR. Real-time PCR was performed using a 
Stratagene Mx3000P thermal cycler, and amplification plots and analysis were 
generated using the accompanying computer software. Each real-time PCR run 
included negative control reactions in which the cDNA template had been 
omitted, to control for any potential contamination. 
Real-time PCR reactions were set up as follows: 
25µl iTaqTM SYBR® Green supermix with ROX (Bio-Rad) 
22µl nuclease free d.H2O 
1µl forward primer 
1µl reverse primer 
1µl cDNA template 
 
PCR conditions used with real-time PCR primers: 
2 minutes at 95˚C initial denaturation step 
40 cycles of: 
1 minute denaturation step at 95˚C 
45 second primer annealing step at 58˚C  
1 minute extension step at 72˚ 
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2.4 Antibody Methods 
 
Table 2.4: Immunohistochemistry buffers and solutions 
 
PBS 10mM phosphate buffer, 2.7mM 
potassium chloride and 137mM sodium 
chloride, pH 7.4 
 
column wash buffer 20mM Na2HPO4 
 
acid elution solution 50mM glycine HCl (pH 2.3) 
 
neutralisation solution 1M Tris (pH10.8) 
 
column storage buffer 20mM Na2HPO4, 0.5M NaCl, 0.01% 
NaN3 
 
PBS-tween PBS with 0.1% v/v Tween-20 
 
coating buffer 15mM Na2CO3, 35mM NaHCO3
 
blocking solution 1% BSA in PBS-Tween 
 
acetate/citrate buffer 1.66M sodium acetate, 33mM citric acid, 
pH6, diluted 1:20 in dd.H2O 
 
TMB 10mg Tetramethyl Benzidine in 1ml 
DMSO 
stop solution 1.84M H2SO4 
 
PBS-Triton X PBS with 0.1% v/v Triton X 
 
fixative solution 4% paraformaldehyde in PBS Triton-X  
 
 42
antibody dilution solution PBS with 0.5% Triton-X, 0.1% BSA, 
0.05% NaN3 
 
 
2.4.1 Production of antisera 
Subunit-specific antigenic peptides were predicted from the translated subunit 
sequence, using the DNA Star Protean software. A hydrophilic, antigenic 
region of ~15 amino acids with a high surface probability was selected from the 
N-terminal region of each sequence as an appropriate peptide for raising 
antisera. This region of ligand-gated ion channel sequence was successfully 
used for the production of antisera by Delany et. al. (1998).The selected 
peptides were synthesised as MAP antigens by Alta Biosciences, UK, and were 
dissolved in sterile PBS at a concentration of 1mg/ml before use. The peptide 
specific for AsUNC-29 was sent to Harlan, UK, for the production of antisera 
in rabbit. The peptides specific for AsUNC-38 and AsUNC-63 were sent to 
Sigma-Genosys, USA, for the production of antisera in goats. 
 
2.4.2 Affinity purification of antisera 
Peptide in a controlled pore glass (CPG) column format was supplied by Alta 
Biosciences, UK, for the purpose of affinity purification. All affinity 
purification procedures were carried out at 4˚C. The composition of the buffers 
and solutions used are listed in Table 2.4. 
The column was washed using approximately 50ml (ie.10x column volume) 
column wash buffer. Tubing and a pump were connected to the column to 
create a recirculating system. 5ml of antiserum was loaded into the column and 
allowed to recirculate overnight at a flow rate of  2-4ml/minute. The serum was 
then drained from the column, and the column was washed with 50ml wash 
buffer. The antibody bound to the column was eluted using acid elution 
solution. 10x 1ml aliquots were collected and immediately neutralised with 
200µl neutralisation solution. The column was again washed with 50ml wash 
solution, and was then stored at 4˚C under column storage buffer. 
The protein content of each of the 10 aliquots eluted from the column was then 
crudely measured by A280. The aliquots with the highest protein content were 
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assumed to contain most of the eluted antibody, and were pooled then dialysed 
overnight against PBS.  
 
2.4.3 ELISA 
A 96-well plate was coated with 100µl of peptide in each well, diluted to 
10µg/ml in coating buffer (see Table 2.4) and incubated at 37˚C for 1 hour, then 
at 4˚C overnight. The plate was washed 3x 15 minutes with PBS-Tween, with 
rigorous expulsion of liquid from the wells between washes. The wells were 
filled with 200µl blocking solution (Table 2.4), and incubated on a shaker for 1 
hour. The plate was then washed with PBS-Tween, 3x 15 minute washes. 
Primary antisera (antiserum from terminal bleed, affinity purified antibody, and 
pre-immune serum) was placed in the first row of wells at 1:100 dilution in PBS 
Tween. This was serially diluted in PBS-Tween across the plate. The plate was 
incubated on a shaker for 2 hours at cool room temperature, then washed for 3x 
15 minutes in PBS-Tween, with rigorous expulsion of liquid from the wells 
between washes. 
Peroxidase-conjugated secondary antiserum (anti-rabbit or anti-goat IgG HRP) 
was diluted 1:2000 in PBS-Tween, and 100µl added to each well. The plate was 
incubated on a shaker for 2 hours at cool room temperature, then washed for 3x 
15 minutes in PBS-Tween, and for 1x 15 minutes in PBS. 
The plate was developed using a solution of 0.5ml TMB and 10µl H2O2 (30% 
v/v) in 49.5ml of acetate/citrate buffer. 100µl of this solution was added to each 
well, and the reaction observed until the colour developed. The reaction was 
then stopped by addition of 50µl stop solution to each well. 
A plate reader was used to measure the A450 values for each well. These values 
were the plotted as a graph of A450 against dilution.  
 
2.4.4 Preparation of muscle cells for immunofluorescence 
Muscle cells were loosened from the cuticle using an adaptation of the 
collagenase treatment protocol described by Johnson and Stretton (1985). The 
worms were pinned in a dissection tray, injected with 500µl 0.5% w/v crude 
bacterial collagenase (Sigma)  in ARS (100µl at 5 equidistant points along the 
worm), and incubated at 37˚C for 1 hour. Worms were then rinsed and the 
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cuticle opened under PBS, allowing the muscle cells to be rinsed out and 
collected using a Pasteur pipette. The muscle cells were allowed to settle slowly 
out of suspension, and the PBS was gently removed and replaced by fixative 
solution. The cells were fixed for ~12 hours, the washed 3 times in PBS-Triton 
X, allowing the cells to settle slowly out of solution as centrifugation can 
damage cell structure. Sections of cuticle with nerve cords attached were also 
dissected from the specimen after collagenase digestion, and were flat-fixed for 
~24 hours between glass slides then washed 3 times in PBS-Triton X.  
 
2.4.5 Immunofluorescence 
Fixed Ascaris suum material was labelled with antibodies for indirect 
immunofluorescence using an adaptation of the methods described by Brownlee 
et al. (1993). Affinity purified antibody was diluted 1:100 in antibody dilution 
solution (see Table 2.4), and 5ml was added to muscle cells or cuticle/nerve 
cord preparations in 15ml tubes. The muscle cells were incubated in primary 
antibody overnight on a roller at 4˚C. The cuticle strips bearing nerve cords 
were incubated in the same manner for ~24 hours. The specimens were then 
washed for 3x 15 minutes in PBS Triton-X. 
Secondary antibody (either FITC conjugated anti-goat IgG or Alexafluor 594 
conjugated anti-rabbit IgG) was diluted 1:200 in antibody dilution solution and 
added to muscle cells or cuticle/nerve cord preparations in 15ml tubes. After 4-
5 hours incubation at 4˚C on a roller, the muscle cells were washed 3x15 
minutes in PBS Triton-X, and mounted on slides under coverslips. Cuticle 
strips bearing nerve cords were subjected to a longer incubation in secondary 
antibody, ~12 hours, before washing and mounting. All  prepared and mounted 
Ascaris suum material was viewed using a Zeiss 510 confocal laser scanning 
microscope. 
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2.5 Xenopus oocyte expression and electrophysiology 
2.5.1 Linearisation of plasmid DNA 
. The Ascaris suum unc-38 and unc-29 sequences were analysed using software 
from the Biology Workbench 3.2 website (http://seqtool.sdsc.edu/CGI/BW.cgi) 
to match restriction sites from the pT7TS plasmid downstream of the Xenopus 
globin 3' UTR to enzymes which would not cut the insert sequence itself. SacI 
was found to be appropriate for the linearisation of both unc-38 and unc-29 
containing plasmids. 
Restriction digests were set up in nuclease free 1.5ml microcentrifuge tubes: 
74µl nuclease free H2O 
10µl 10x reaction buffer 
1µl BSA (10mg/ml) 
5µl restriction enzyme  
10µl plasmid (~1µg/µl) 
The reactions were incubated at 37˚C for 2-3 hours. 
 The linear DNA was then purified by phenol-chloroform extraction. 200µl 
nuclease-free H2O and 300µl phenol:chloroform:isoamyl alcohol (25:24:1, 
Sigma-Aldritch) were added to the digest reaction mixture, and vortex mixed. 
Centrifugation at 13000 x g for 2 minutes was carried out to allow phase 
separation. The upper aqueous layer was transferred to another nuclease-free 
tube, and an equal volume of chloroform added. The sample was again vortex 
mixed then centrifuged at 13000g for 2 minutes. The aqueous layer containing 
the DNA was removed to another nuclease-free tube, and 30µl 3M sodium 
acetate and 720µl of absolute ethanol were added. The tube was placed at -20˚C 
overnight to allow the DNA to precipitate. The DNA was recovered by 
centrifugation at 13000 x g and 4˚C for 15 minutes. The supernatant was 
removed, and the DNA allowed to dry for ~5 minutes before resuspension in 
10µl nuclease-free H2O. 
 
2.5.2 In vitro transcription 
In vitro transcription of the linear DNA was carried out using the T7 
mMESSAGE mMACHINE kit (Ambion). This kit transcribes the sequence 
starting from the T7 site, which in pT7TS is upstream of the insert and the 
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Xenopus β-globin UTRs. Transcription reactions were set up in RNase-free 
microcentrifuge tubes: 
3µl   nuclease-free H2O 
10µl   2x NTP/Cap 
 2µl   10x Reaction Buffer 
 3µl   linear template DNA 
 2µl   enzyme mix 
The reactions were incubated at 37˚C for 2 hours, then the DNA template 
removed by addition of 1µl DNaseI and a further incubation at 37˚C for 15 
minutes. The reaction was then stopped by addition of 15µl ammonium acetate 
stop solution, and the volume was made up to 150µl by addition of nuclease-
free H2O.  
The cRNA was then purified by phenol-chloroform extraction. An equal 
volume of phenol:chloroform (5:1, Sigma-Aldrich) was added to the reaction 
mixture, vortex mixed, then centrifuged at 13000 x g for 2 minutes to allow 
phase separation. The upper aqueous phase was removed to a clean nuclease-
free microcentrifuge tube, and an equal volume of chloroform added. The 
sample was again vortex mixed then centrifuged at 13000 x g for 2 minutes. 
The aqueous layer containing the RNA was removed to another nuclease-free 
tube, and 150µl isopropanol added. The RNA was precipitated by placing at -
20˚C overnight, then recovered by centrifugation at 13000 x g and 4˚C for 15 
minutes. The supernatant was removed and the RNA dried at room temperature 
for ~5 minutes before resuspension in 10µl nuclease-free H2O. The 
concentration of RNA was quantified by A260 using a spectrophotometer. The 
concentration of each subunit cRNA was adjusted to 1µg/µl by dilution with 
nuclease free water. 
 
2.5.5 Microinjection of oocytes 
 
The oocytes were incubated in incubation medium (table 2.5). All 
manipulations of oocytes were carried out using 3ml plastic pasteur pipettes and 
a fine paintbrush. The oocytes were stabilised during injection procedures by 
placing them in 35mm petri dishes onto which grooves of the correct width to 
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accommodate oocytes had been scored using a heated razor blade. Injection 
needles were pulled from 3.5nl glass capillary tubes (World Precision 
Instruments, USA) using a p-2000 needle puller (Sutter Instrument Company, 
USA) with the settings heat=335, fil.=4, vel.=45, del.=250, pull=150. The 
needle tips were broken off using fine forceps, and the needles back-filled with 
mineral oil and attached to the Drummond ‘Nanoject’ microinjector. The needle 
was filled with the appropriate cRNA solution, and each oocyte was injected 
with 50nl of cRNA (approximately 40ng). The oocytes were placed in 35mm 
petri dishes in fresh incubation medium and incubated at 18 ºC for 48-72 hours, 
with daily changes of medium. After 72 hours, oocytes were maintained at 4 ºC 
up to a maximum time of 5 days post-injection. 
 
2.5.6 Two-electrode voltage clamp 
 
Recordings were made 2-4 days after RNA injection. Microelectrodes were 
pulled from 1.17mm interior diameter borosilicate capillary tubing (Warner 
instruments, order no. 64-0805) using a p-2000 needle puller (Sutter Instrument 
Company, USA) with the settings heat=355, fil.=4, vel.=50, del.=225, pull=75. 
The microelectrodes were backfilled with 3M KCl solution using a long fine 
needle. After attachment to the headstage, the resistance of the electrodes was 
checked to ensure it was between 0.5 and 5Ω, and the voltage of each electrode 
was zeroed.  
The eggs were placed in the bath, impaled with the electrodes, and continuously 
perfused with SOS to which 0.5µM atropine had been added, to inhibit any 
endogenous muscarinic receptors which may also respond to acetylcholine. 
Current was applied sufficient to hold the membrane potential at -60mV, 
applied and measured using a GeneClamp 500 amplifier (Axon Instruments). 
Perfusion was delivered by a ValveLink 8.2 digitally controlled perfusion 
system (AutoMate Scientific, USA). Agonists and antagonists (obtained from 
Sigma) were dissolved to the required concentrations in SOS. Agonists were 
perfused for 5 second intervals, then washed off by perfusion of SOS. 
Antagonists were perfused for 30 seconds prior to application of agonist; wash 
off was achieved by further perfusion of SOS. Agonist doses were applied at 3 
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minute intervals to allow receptor recovery from any desensitisation. Responses 
to cholinergic agonist application were measured as changes in injected current 
needed to maintain membrane holding potential. The data were digitized using 
the Digidata 1322A (Axon Instruments); responses were recorded and 
quantified using the pClamp software Clampex 8.2 and Clampfit 8.2. Data were 
then exported to GraphPad Prism for statistical analysis. Data were normalised 
to the response to 100µM ACh for each individual oocyte, and a sigmoidal 
dose-response curve for each agonist was fitted using non-linear regression. 
 
Table 2.5: Solutions used for oocyte incubation and electrophysiology 
 
Standard Oocyte Saline (SOS) 100mM NaCl 
1mM MgCl2 
5mM HEPES 
2mM KCl 
1.8mM CaCl2 
pH 7.5 
Incubation medium Standard oocyte saline  
2.5mM pyruvate 
100µg/ml penicillin 
100µg/ml streptomycin 
50µg/ml gentomycin 
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 Chapter 3: Bioinformatics 
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 3.1 Introduction  
The model nematode C. elegans has the largest known nAChR gene family, 
with ~30 nAChR subunit genes (Brown et al., 2006). However, prior to the start 
of the work presented here, little was known about the nAChR gene families of 
other nematodes, though putative homologues of unc-38, which encodes an α-
subunit of C. elegans levamisole-sensitive nAChR, had been identified in a few 
nematode parasites (Ajuh & Egwang, 1994; Hoekstra et al., 1997; Walker et 
al., 2001). In insects, the nAChR gene family found in the model dipteran 
Drosophila melanogaster has provided a basis from which the genomes of 
other insects can be searched to identify nAChR subunit genes based on their 
homology to Drosophila sequences. This approach has been successfully 
applied to insect groups phylogenetically distinct from flies, such as the honey 
bee Apis mellifera, the flour beetle Tribolium castaneum (Jones & Sattelle, 
2006; Jones & Sattelle, 2007). 
As the genome sequence of Ascaris suum was unavailable at the beginning of 
this project, it was decided that a search of the genome of a related parasite, 
Brugia malayi, may provide useful information about which nAChR subunit 
genes were likely to be present in Ascaris suum. Brugia malayi and Ascaris 
suum both belong to the clade III phylogenetic group, whereas C. elegans 
belongs to the phylogenetically distinct clade V (Blaxter et al., 1998). As the 
nAChR gene family of the model nematode C. elegans has been extremely well 
described, C. elegans nAChR subunit sequences were used as query sequences 
for performing searches of the parasite genome (Jones et al., 2007; Jones & 
Sattelle, 2004). When this search had been completed, the search for nAChR 
subunit genes was extended to the genome of another phylogenetically distinct 
parasite, the clade I nematode Trichinella spiralis. A summary of the steps 
involved in performing a reciprocal BLAST search to identify putative nAChR 
subunit genes is shown in Figure 3.1. The methods are described more fully in 
section 2.2.  
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Figure 3.1: Identification of putative homologues of C. elegans nAChR 
genes in parasite genomes 
The flowchart summarises the methods used to identify putative homologues of 
C. elegans nAChR subunit genes from the genome sequences of Brugia malayi 
and Trichinella spiralis.  
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 3.2 The nAChR gene families of Brugia malayi and 
Trichinella spiralis 
Although C. elegans has the largest known nAChR gene family, with ~ 30 
genes, searches of the genomes of Brugia malayi and Trichinella spiralis reveal 
far fewer apparent nAChR subunits: 9 and 8 respectively. These results are 
summarised in Table 3.1, and are presented as a tree of sequence similarity in 
Figure 3.2. The tree of sequence similarity is based on a ClustalX alignment of 
the translated parasite nAChR subunit sequences against their putative 
homologues from C. elegans. 
Notable absences of particular relevance to the work presented here are certain 
proposed components of the levamisole receptor; lev-1 and lev-8 were not 
found in the genomes of either parasite species (Fleming et al., 1997; Lewis et 
al., 1980; Towers et al., 2005). However, the other nAChR subunits thought to 
comprise the C. elegans levamisole-sensitive receptor, unc-38, unc-29 and unc-
63, are present and highly conserved in both parasites (Culetto et al., 2004; 
Fleming et al., 1997). Another notable absence in terms of anthelmintic targets 
was acr-23. The nAChR subunit this gene encodes is believed to be the target 
of the new cholinergic anthelmintic compounds the AADs, but acr-23 was not 
present in the genomes of these clade III and clade I parasites (Kaminsky et al., 
2008). A further difference between the nAChR gene families of the two 
parasites investigated and that of C. elegans is the apparent absence of acr-16, 
which encodes a subunit forming a homomeric levamisole-insensitive 
neuromuscular nAChR (Touroutine et al., 2005). The acr-16 group of C. 
elegans contains 11 subunits, whereas Brugia malayi and Trichinella spiralis 
only possess one subunit sequence each from this group; it is a different one in 
each species, and neither appears truly homologous to acr-16. All the other 
nAChR subunit groups from C. elegans, which have been described on the 
basis of sequence similarity, also contain fewer members in the parasites. An 
additional nAChR subunit not present in C. elegans is found in the Brugia 
malayi genome, and is also the only nAChR subunit sequence present in the 
Ascaris EST library. This divergent subunit is most similar to nAChR subunit G 
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from the pond snail Lymnaea stagnalis (van Nierop et al., 2006), and is 
apparently conserved amongst clade III nematodes, though it was not found in 
the genome of the clade I nematode Trichinella spiralis. With the agreement of 
the annotators of the C. elegans nAChR subunits (Andrew Jones and Jonathon 
Hodgkin, personal communication) this sequence was named acr-26; acr- is the 
prefix given the nAChR subunits not already named by phenotype, and 26 is the 
logical designation for a nAChR subunit additional to the 25 acr's already 
named in C. elegans (Jones et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 54
  
Table 3.1: Summary of nAChR subunit sequences from in Brugia malayi 
and Trichinella spiralis: a comparison with C. elegans 
 
The complete list of C. elegans nAChR subunits used for this comparison, the 
nomenclature used, and the assignment of nAChR subunits to groups based on 
sequence similarity, is as described by Jones et al. (2007).  
C. elegans 
nAChR subunit 
group 
Present in B. 
malayi 
Absent from 
B. malayi 
Present in 
Trichinella 
spiralis 
Absent from 
T. spiralis 
unc-38 group unc-38 
unc-63 
acr-6 unc-38 
unc-63 
acr-6 
unc-29 group unc-29 lev-1 
acr-2 
acr-3 
unc-29 
acr-3 
lev-1 
acr-2 
acr-8 group acr-8 
acr-12 
lev-8 acr-8 
acr-12 
lev-8 
deg-3 group deg-3 
des-2 
acr-5 
acr-17 
acr-18 
acr-20 
acr-23 
deg-3 des-2 
acr-5 
acr-17 
acr-18 
acr-20 
acr-23 
acr-16 group acr-11? eat-2 
acr-7 
acr-9 
acr-10 
acr-14 
acr-15 
acr-16 
acr-19 
acr-21 
acr-25 
acr-19 eat-2 
acr-7 
acr-9 
acr-10 
acr-11 
acr-14 
acr-15 
acr-16 
acr-21 
acr-24 
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 Figure 3.2: The nAChR gene families of Brugia malayi and Trichinella 
spiralis  
Boot-strapped neighbour-joining tree generated from a ClustalX alignment of 
the translated nAChR sequences found in the genome sequences of B. malayi 
and T. spiralis, aligned with their C. elegans homologues. Genes found by 
Ghedin et al.2007 are described by the published locus number; otherwise our 
own proposed nomenclature is used, utilising the C. elegans gene names along 
with a prefix to designate the nematode species (Williamson et al., 2007). 
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3.3 The use of consensus nAChR sequences for primer 
design 
The primary reason for carrying out searches for nAChR subunit sequences in 
the  genome of Brugia malayi was to predict which nAChR subunits were 
likely to be present in Ascaris suum, so attempts could be made to amplify these 
using PCR. Amplification of nAChR subunits for which partial sequences were 
not already present in the databases would require the use of degenerate 
primers, which are designed on regions of amino acid sequence conserved 
between species. Alignments were made of the translated sequences of well-
conserved nAChR subunits from C. elegans and Brugia malayi using ClustalW. 
Figure 3.3 shows ClustalW alignments used for the design of degenerate 
primers designed to amplify unc-29 and unc-63. Conserved regions featuring 
amino acids with the fewest possible combinations of codons were chosen for 
primer design, to minimise the degeneracy.  
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 Figure 3.3: ClustalW alignments of the nAChR subunit sequences UNC-29 
and UNC-63 from C. elegans and B. malayi.  
The amino acid sequences of UNC-29 and UNC-63 are well-conserved between 
C. elegans (lower rows, labelled with subunit name) and B. malayi (upper rows, 
labelled "brugia"). Conserved residues are indicated by an asterisk. Regions 
used for degenerate primer design are highlighted, with arrows above the 
sequence indicating the direction of amplification for which the primer would 
be used. 
 
a) UNC-29 
brugia          --------------------------SDEEERLMVDVFRGYNSLIQPVRNLNETPIIVKI 34 
unc29           MRTNRLSWILVLSVVIFLVIINTINASDDEERLMVDVFRGYNSLIQPVRNSSELPLIVKM 60 
                                          **:********************* .* *:***: 
                           > 
brugia          ALQLALLINVDEKDQIMHTNVWLTL-WHDFQMRWNPVDYGEIQNIRVAPDKVWLPDIVLF 93 
unc29           ALQLVLLINVDEKDQVMHTNVWLTLQWHDFQMKWNPVNYGEIKQIRVSPDKVWLPDIVLF 120 
                ****.**********:********* ******:****:****::***:************ 
                             <  > 
brugia          NAADGNYEVSFMCNVVINYKGEMLWVPPAIYKSSCIIDVEFFPFDEQTCHLIFGSWTYNE 153 
unc29           NNADGNYEVSFMCNVVINHKGDMLWVPPAIYKSSCIIDVEFFPFDEQVCTLVFGSWTYNE 180 
                * ****************:**:*************************.* *:******** 
 
brugia          NEIKLEFEQAEWVDLSEYAPSSIWDVMDAPAVLVNKRSRIEFQVRIRRKTLFYTVVLIIP 213 
unc29           NEIKLEFVQAELVDVSEYSASSIWDVIDVPASLVNKRSRIEFQVRIRRKTLFYTVVLIIP 240 
                ******* *** **:***:.******:*.** **************************** 
 
brugia          TVLMAFLSMAVFFLPTDSGEK-----------------------------PLMAKYLLLT 244 
unc29           TVLMAFLSMAVFFLPTDSGEKITLTISVLLSIVVFLLLVSKILPPTSSTIPLMAKYLLLT 300 
                *********************                             ********** 
 
brugia          FVLNVITILVTVIIINVYFRGPTTHRMPKWVRTVFLQ--PKLLCMQRPKPLLRNFTQKNG 302 
unc29           FVLNVITILVTVIIINVYFRGPRTHRMPQWVRVVFLQFLPKLVCMKRPKSASERSAVRSG 360 
                ********************** *****:***.****  ***:**:***.  .. : :.* 
 
brugia          HPITAAFPDISELKLNPSIHHPLCPSAD-------------TSAYYPLSPDALRAIDAIE 349 
unc29           ---MAQLPGVGQFTLSPSAHHPLCPSADDRTTTIRNTASNETSAYYPLSTDALRAIDAIE 417 
                  : * :*.:.::.*.** *********             ********.********** 
         < 
brugia          YIN-HLKQDEEYKMVRDDWKYVAMIIDRLLLYVFFGITVGGTCGILFSAPYVFQGVDQRA 408 
unc29           YITEHLKRDEQHKSFRDDWKYVAMIIDRLLLYVFFGITVGGTCGILFSAPHVFQRIDQQE 477 
                **. ***:**::* .***********************************:*** :**:  
 
brugia          ELQRLIHLYKNGG--- 421 
unc29           MLDRLKEKYDTASNIP 493 
                 *:** . *....    
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b) UNC-63 
 
 
brugia          ------------------------QDAGRLIEDLLADYNKLVRPVENDSDTLIVRLKLKL 36 
unc-63          MGPNDHGFAYILIFLLLSPPTHANRDANRLFEDLIADYNKLVRPVSENGETLVVTFKLKL 60 
                                        :**.**:***:**********.::.:**:* :**** 
                              > 
brugia          SQLLDVHEKNQIMTTNVWLQH-WTDYKLKWNPADYGGVTVLYVPSDMIWLPDIVLYS-AD 94 
unc-63          SQLLDVHEKNQIMTTNVWLQHSWMDYKLRWDPVEYGGVEVLYVPSDTIWLPDVVLYNNAD 120 
                ********************* * ****:*:*.:**** ******* *****:***. ** 
 
brugia          GNYQVSIMTKAKLSPNGTVEWSPPAIYKSMCQIDVEWFPFDIQTCEMKFGSWTYGGLEVD 154 
unc-63          GNYQVTIMTKAKLTYNGTVEWAPPAIYKSMCQIDVEFFPFDRQQCEMKFGSWTYGGLEVD 180 
                *****:*******: ******:**************:**** * **************** 
        < 
brugia          LQHKD---------------------------GIDLSDYYPSVEWDILGVPGKRHLKRYP 187 
unc-63          LQHRDKHLEKEIEEDVEGVDGPTKEIVWVVDRGIDLSDYYPSVEWDILNVPGKRHSKRYP 240 
                ***:*                           ****************.****** **** 
 
brugia          CCESPFIDLTYEIRLRRKTLFYIVYLIFPIVSISFLTVLVFYLPSDGGEKISLCLNILIS 247 
unc-63          CCESPFIDITYEIHLRRKTLFYTVNLIFPSVGISFLTALVFYLPSDGGEKISLCISILIS 300 
                ********:****:******** * **** *.*****.****************:.**** 
                                                                        
brugia          LTIFFLLLVEIIPSTSLVIPLIGKY---------------------HFRSPSTHTMPEWT 286 
unc-63          LTVFFLLLVEIIPSTSLVIPLIGKYLLFTMVLVTLSVVVTVVTLNVHYRSPTTHTMPKWM 360 
                **:**********************                     *:***:*****:*  
 
brugia          KRIFIEFLPKYLLMRRPSP---------------SSFAS--------------------- 310 
unc-63          KRLFVDFLPKYLLMTRPQPPGHHSKPNRKFDSRASTFSIGVNHVLGQNSELLSPGLNSNR 420 
                **:*::******** **.*               *:*:                       
                                                       
brugia          ------FQKELTPVMSAVDSVTFIASHMKDDKNGQQVIEDWKYISVVMDRLFLILFTTAC 364 
unc-63          EESSFTLPRDNSPVRSAVESVAYIADHLKNEEDDKQVIEDWKYISVVMDRIFLITFTFAC 480 
                      : :: :** ***:**::**.*:*::::.:***************:*** ** ** 
 
brugia          MIGSILIILRAPTLYDTTIALA 386 
unc-63          AFGTVVIIARAPSIYDNTPALA 502 
                 :*:::** ***::**.* *** 
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3.4 Discussion 
 
A bioinformatics approach to investigating the nAChR gene families of parasitic 
nematodes for which good quality genome sequence is available has revealed a 
surprisingly small nAChR gene family in Brugia malayi and Trichinella spiralis 
compared to C. elegans. The close correlation between the nAChR subunits found in 
both parasites, and the fairly complete and assembled nature of these genome 
sequences, suggests that this is indeed the full extent of these nAChR gene families. 
Support for this comes from work using the genome of Haemonchus contortus, a 
clade V nematode quite closely related to C. elegans, which has also been carried out 
in our laboratory. Although the genome sequencing project of Haemonchus contortus 
is much less complete than the parasite genome sequences used here, the majority of 
the C. elegans nAChR subunit genes (~25) were easily identified (Thomas Walsh, 
personal communication). The results presented here also broadly agree with the 
annotation accompanying the Brugia malayi genome in terms of the number of 
nAChR subunits present, which was published after the work described in this chapter 
had been completed. However, the annotators of the Brugia malayi genome utilised a 
rather confusing and inconsistent nomenclature when describing the nAChR subunits, 
where C. elegans gene names were assigned to non-homologous Brugia malayi 
sequences (Ghedin et al., 2007). Figure 3.2 utilises the nomenclature we proposed in 
Williamson et al. 2007, where C. elegans gene names are assigned to parasite nAChR 
subunit sequences which are clearly homologous to C. elegans sequences, and a 
prefix is added to denote the genus and species to which the sequence belongs. This 
nomenclature has the support of the C. elegans nAChR community, and a similar 
strategy has been used to ensure consistency when annotating the insect nAChR gene 
families (Andrew Jones and Jonathon Hodgkin, personal communication; Jones et al. 
2007).  
The degree of conservation between putatively homologous nAChR subunits from the 
different nematode species was variable both within and between nAChR subunits; 
the ligand-binding motifs and the transmembrane regions were usually quite similar, 
but the cytoplasmic region was too dissimilar to be identified from genomic sequence 
in the majority of cases. It would therefore be misleading to attempt to quantify the 
similarity of homologous nAChR sequences from the regions which could be 
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identified in silico; a more complete comparison would require the amplification and 
sequencing of all these parasite nAChRs, which is beyond the scope of the work 
presented here. The most highly conserved nAChR subunit sequences (in terms of the 
amount of matching sequence which could be easily identified in the parasite 
genomes) appeared to be unc-38, unc-29 and unc-63; this provides a good basis for 
the design of primers to amplify these subunits from other nematode species. The high 
degree of conservation suggests these subunits have an essential role in cholinergic 
signalling in nematodes. When the proposed role of these subunits as components of 
the levamisole receptor and their changing expression levels in pyrantel resistant 
hookworms are considered, investigating the function of these nAChR subunits in 
parasites is clearly key to understanding both sensitivity and resistance to this class of 
cholinergic anthelmintic (Fleming et al., 1997; Kopp et al., 2008). In contrast to this, 
the lack of acr-23 in Brugia malayi and Trichinella spiralis suggests that if the AAD 
compounds do in fact have activity against these nematodes, they must act via a 
different target to the one described from C. elegans (Kaminsky et al., 2008).  
The findings presented here suggest that either the nematode nAChR gene family 
underwent a dramatic expansion in the clade V nematodes, or that nAChR genes have 
been lost from B. malayi and T. spiralis. Either hypothesis may suggest that this lack 
of nAChR diversity is linked to the different neurotransmission requirements of a 
free-living versus a parasitic lifestyle; it should be noted that larvae of many parasitic 
clade V species must survive outside a host while they develop to an infective stage, 
whereas transmission from host to host is usually more direct for parasites from 
clades III and I (Dorris et al., 1999). An alternative explanation for the smaller 
number of nAChR genes present in these parasites could also be a greater degree of 
alternative splicing; though insects possess only a small number of nAChR genes, 
they are known to increase their receptor repertoire by splicing and editing mRNA 
(Sattelle et al., 2005). No evidence to support this hypothesis has yet emerged from 
the parasite genomes, but this cannot be entirely ruled out without performing 
amplification of all the nAChR subunit transcripts generated by the nematodes. 
While the dramatic difference in the number of nAChR gene family members 
between C. elegans and the parasites Brugia malayi and Trichinella spiralis is 
certainly intriguing, it should be noted that it is currently unknown whether the 
genomes of these parasites are typical of the clades to which they belong. A more 
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complete comparison of the gene families of nematodes from different clades cannot 
be carried out until many more nematode genomes have been successfully sequenced.  
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Chapter 4: Amplification of nAChR subunits 
from Ascaris suum 
 63
 
4.1 Introduction 
 
To investigate the molecular basis of cholinergic anthelmintic sensitivity in a parasitic 
nematode, the starting point must be to amplify sequences encoding nAChR subunits 
which are potential components of the relevant receptor. For the model nematode C. 
elegans, a comprehensively sequenced and annotated genome, and the ease with 
which drug resistant mutants can be produced and maintained in vitro, has greatly 
facilitated the identification of nAChR subunits forming anthelmintic drug targets. 
For parasitic nematodes, a relative paucity of genomic information, and the 
difficulties involved in producing or isolating drug resistant worms, makes the task of 
investigating the molecular basis of drug sensitivity and resistance much more 
difficult. It should be noted that even when some sequence information is available 
for a parasite in the form of an EST library, this is often biased towards the most 
abundant transcripts, and rarely provides more than two or three partial sequences for 
ligand-gated ion channels. However, several previous studies have succeeded in 
amplifying a limited number of nAChR subunits from nematode parasites, using two 
main approaches. Parasite homologues of unc-38 were obtained from both 
Haemonchus contortus and Trichostrongylus colubriformis by constructing and 
screening  genomic DNA libraries (Hoekstra et al., 1997; Wiley et al., 1996). 
Degenerate PCR using primers based on the amino acid sequence of C. elegans 
nAChR subunits yielded the Teladorsagia circumcincta unc-38 homologue, and was 
more recently employed to facilitate amplification of several nAChR sequences from 
Ancylostoma caninum which could not be located by searches of the A. caninum 
sequence database (Kopp et al., 2008; Walker et al., 2001). Both these approaches 
rely heavily on a high degree of sequence similarity between the sequence being used 
as a probe or for primer design and the sequence the experiment is designed to obtain; 
all the parasites mentioned in the previous examples are from clade V and are 
therefore closely related to each other and to the model nematode C. elegans. In the 
work presented here, it was hoped that degenerate PCR utilising primers designed 
using the sequence information from the clade III parasite Brugia malayi would allow 
amplification of nAChR subunits from Ascaris suum (described in section 3.3). This 
approach was used to amplify partial sequence of Ascaris suum unc-29 and unc-63. 
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An existing partial sequence in the GenBank database and the Ascaris suum EST 
database was used to design primers specific to Ascaris suum unc-38, and an 
additional novel nAChR subunit. After partial nAChR subunit sequences had been 
obtained, RACE techniques were used to amplify the 5' and 3' ends of the sequences 
(Frohman et al., 1988). RACE techniques have previously been used successfully to 
obtain full-length transcripts from Ascaris spp. (Timinouni & Bazzicalupo, 1997). As 
a modification to the RACE protocol, the nematode splice leader sequence SL1 was 
used as the 5' RACE primer. SL1 is a splice-leader element found at the 5' end of the 
many of nematode mRNA sequences, and has previously been successfully used as a 
5' RACE primer for amplification of nematode transcripts (Bektesh et al., 1988; Pape 
et al., 1999). 
 
4.2 Potential components of the levamisole-sensitive nAChR 
from Ascaris suum 
Full length sequences encoding homologues of unc-38 and unc-29 were amplified 
from Ascaris suum body wall muscle. The process by which these sequences were 
obtained is summarised in Figure 4.1. These sequences were deposited in the 
GenBank database, with the accession numbers EU053155 and EU006073. Figure 4.2 
shows the translated sequences of Ascaris suum UNC-38 and UNC-29, where some 
key features are highlighted. Like the homologous C. elegans sequence, Ascaris suum 
unc-38 encodes a nAChR α subunit, containing amino acid residues from the principal 
binding loops A, B and C known to contribute to ligand binding (see Figure 1.4, 
which is taken from Changeux & Taly, 2008) . The loop C motif for both the C. 
elegans and Ascaris suum unc-38 is Y-X-X-C-C, rather than the more usual Y-X-C-C. 
This additional loop C residue is a proline known to be involved in the differential 
sensitivity of nematode and mammalian muscle nAChRs; another residue conferring 
this differential levamisole sensitivity is a glutamic acid present on loop B, which is 
again conserved in both C. elegans and Ascaris suum (Rayes et al., 2004). The 
Ascaris suum unc-29 sequence, like the homologous sequence from C. elegans, 
encodes a non-α subunit, lacking the principal binding components but possessing the 
ligand-binding residues of the complementary binding loops D, E and F (see Figure 
1.4, which is taken from Changeux & Taly, 2008). Both Ascaris suum UNC-38 and 
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UNC-29 possess the charged glutamic acid and aspartic acid residues near the base of 
the second transmembrane domain indicating that they are components of a cation 
channel (see Figure 1.5, taken from Corringer 2000). This is an important distinction 
for a nematode nAChR, as C. elegans is known to possess acetylcholine-gated anion 
channels (Putrenko et al., 2005). 
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Figure 4.1: Reverse transcription, amplification, and 5' and 3' RACE 
 
The schematic shows the different steps involved in obtaining full-length coding 
sequence for a nAChR subunit sequence. 1) The starting material is mRNA extracted 
from nematode tissue. Most nematode mRNA has the splice leader sequence SL1 at 
the 5' end. Also shown is the 3' polyA tail of the mRNA. 2) During reverse 
transcription, a known anchor sequence is added to cDNA using an oligt dT primer 
complementary to the polyA tail with this sequence added. 3) A partial sequence of 
the transcript of interest is amplified by PCR using either degenerate or specific 
primers. 4) 5' RACE: the known sequence is extended using a forward primer 
complementary to SL1 and a reverse primer specific for the sequence of interest. 5) 3' 
RACE: the known sequence is extended using a reverse primer complementary to the 
anchor sequence added during reverse transcription, and a forward primer specific to 
the transcript of interest. 6) The whole sequence is now known, and primers to 
specifically amplify the coding region of the transcript of interest can be designed 
using the sequence around the start and stop codons. 
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Figure 4.2: The sequences of Ascaris suum UNC-38, UNC-29 and UNC-63  
 
The translated sequences of amplified Ascaris suum nAChR subunits which may 
potentially be components of a levamisole-sensitive nAChR are shown:  a) full-length 
sequence of UNC-38, b) full-length sequence of UNC-29, c) partial sequence of 
UNC-63. Regions of the sequences are highlighted to display relevant features of the 
proteins: lower case letters = predicted signal peptide, turquoise = residues necessary 
for levamisole sensitivity (Changeux & Taly, 2008; Rayes et al., 2004), red = ligand 
binding residues (Brejc et al., 2001; Changeux & Taly, 2008), green = anionic 
residues indicative of cation channel specificity (Corringer et al., 2000), yellow = 
transmembrane domains. 
 
a) UNC-38 
 
mfglleallwlvvcgtsLTVGNEDAKRLYDDLMVNYNKHRRPAMSPHEPVTIKLKLRLSQIIDVHEIDQIMTYSVW 
 
LKQVWIDKKLSWDPKNYGGVSVLYVPYEMIWVPDIVLYNNADSNYNITISTKATLHYSGEVTWEPPAIFKSMCQID 
                      
VRWFPFDEQKCHLKFGSWTYSEDLLVLELLDGEPHYELETNEFGEVDNITIVDDGIDLSDYYPSVEWDIMSRVAIR 
                      
RTKNYPSCCPQSDAYIDIMYYLELRRKPLFYTVNLVFPCVGISFLTILVFYLPSDSGEKVTLCISILVALTVFFLL 
 
LTEIIPATSISLPLIGKYLLFTMVMVTLSVVVTVISLNLHFRTPTTHRMPEWVKWLFLKFLPKVLFMRRPLADTDD 
                      
TYRRVSQRRGDNCEKVAINYHEHRVSRDIGRALSTSPVDERIQKLYYSPAVVKAFENVCFIAELLKKKDRDDKVDE 
                      
DWKYVAMVLDRLFLLLFSFACFIGTVTILLQAPTLYDSREAIDLQYRPANISTPVTQ 
 
 
b) UNC-29 
 
mhlpspaliivyyvlvallragvvlcSDDEERLMVDVFRGYNSLIQPVRNLSDTPIIVKIALQLVLLINVDERDQV 
 
MHTNVWLTLKWHDFQMKWNPVNYGEIQNIRVAPDKVWLPDIVFFNNADGNYEVSFMCNVVISHKGDMLWVPPAIYK 
                      
SSCIIDVEFFPFDEQTCHLIFGSWTYNENEIKLEFEQAEWVDLSEYAPSSIWDVMDAPASLVNKRSRIEFQVRIRR 
                                       
KTLFYTVVLIIPTVLMAFLSMAVFFLPTDSGEKMTLTISVLLSIVVFLLLVSKILPPTSSTIPLMAKYLLLTFVLN 
                      
VITILVTVIIINVYFRGPTTHRMPKWVRTTFLQVMPKLLCMQRPKQLLRKMAAHAAAQQANGAAVATALPGIGEFT 
 
LNPSAHHPFCPSADDSRFHPPSIELTHVDSVRQFERDPMTSAYYPLSADALRAIDAIEYITDHLKQDEEYKMYRDD 
                      
WKYVAMIIDRLLLYVFFGITVGGTCGILFSAPYVFQGVDQRAELQRLIHLYKNGGEI 
 
 
c) UNC-63 (partial sequence of ligand binding domain only) 
mpclriilwmvlslqlkqssNKDASRLFEDLLADYNKLVRPVDNNSETLIVRFKLKLSQLLDVHEKNQIMTTNVW 
 
LQHSWTDYKLKWNPADYGGVDVLYVPSEMIWLPDVVLYNNADGNYQVTIMTKAKVSSNGTVEWAPPAIYKSMCQID 
 
VEFFPFDAQTCEMKFGSWTYGGLEVDLKHKDSHKEREELETVLGLDGEYEETVWIVDEGIDLSDYYPSVEWDILRV 
 
PGKRHEKR 
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 Only a partial sequence of Ascaris suum unc-63 was obtained, which was initially 
interpreted as being caused by due to mis-priming of the mRNA polyA tail during 
reverse transcription, as the nucleotide sequence obtained had  regions containing 
many adjacent adenine bases. This possibility was eliminated by altering the reverse 
transcription primers for a mixture of random hexamers; it was still not possible to 
amplify any further unc-63 sequence from Ascaris cDNA despite using several 
different degenerate PCR primers. The sequence obtained did however appear to 
encode a partial ligand-binding domain of a nAChR α subunit homologous to C. 
elegans unc-63. This partial sequence is also shown in Figure 4.2. 
Tables 4.1, 4.2 and 4.3 show the similarity of the Ascaris suum UNC-38, UNC-29 and 
UNC-63 to other nAChR subunits at the amino acid level. The top 5 most similar 
sequences returned from a search of the GenBank database using the TBLASTN 
algorithm are included in each table. In the majority of cases, homologous sequences 
from other nematode species were returned by the search, in which case only the 
nematode genus and species is included in the table. Where one of the matching 
sequences was not from a nematode, the genus and species of the organism 
concerned, and the designated name for the nAChR subunit using nomenclature 
appropriate for that species, are included. It should be noted that bias may be 
introduced into these results by partial sequences, either used as a search query, or as 
a returned matching sequence from the database. In summary however, there is 
clearly much greater similarity between homologous nAChR subunits from different 
nematodes than there is similarity with nAChR subunits from different phyla. As a 
point of comparison, a similar BLAST search using the Ascaris suum sequences was 
performed but the results restricted to human nAChR sequences. These generally 
showed  roughly 40% identity to the nematode subunits, though surprisingly, UNC-38 
and UNC-63 appeared slightly more similar to human α6 and α4, and UNC-29 to 
human β2, than to the human muscle nAChR subunits. The similarity of UNC-29 to 
β2 is also apparent in the conserved ligand binding residues (Brejc et al., 2001). 
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 Table 4.1: Similarity between Ascaris suum UNC-38 and the 5 most similar 
nAChR subunits returned by a search of the GenBank database using the 
TBLASTN algorithm 
 
Species Percentage 
identity 
Accession number 
Haemonchus contortus  
 
86% U72490 
Caenorhabditis elegans  
 
80% NM_059071 
Ancylostoma caninum  
 
77% EU852579 
Brugia malayi (partial sequence)  
 
78% XM_001901151 
Onchocerca volvulus (partial sequence) 
 
73% L12543 
 
 
Table 4.2: Similarity between Ascaris suum UNC-29 and the 5 most similar 
nAChR subunits returned by a search of the GenBank database using the 
TBLASTN algorithm. 
 
Species Percentage
identity 
Accession number 
Brugia malayi  
 
89% XM_001898590 
Haemonchus contortus  
 
81% EU006786 
Ancylostoma caninum 
 
81% EU852580 
Caenorhabditis elegans 
 
77% NM_059998 
Caenorhabditis briggsae 
 
79% XM_001668341 
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Table 4.3: Similarity between Ascaris suum UNC-63 and the 5 most similar 
nAChR subunits returned by a search of the GenBank database using the 
TBLASTN algorithm. 
 
Species, nAChR subunit name (if not a 
clear homologue from another nematode 
species) 
Percentage 
identity 
Accession number 
Haemonchus contortus 
 
81% EU006787 
Ancylostoma caninum 
 
81% EU852581 
Caenorhabditis elegans 
 
77% NM_059132 
Brugia malayi (partial sequence) 
 
79% XM_001899057 
Bemesia tabaci α-3 subunit 
 
57% AJ880081 
 
 
4.3 A novel nAChR subunit from Ascaris suum 
An additional nAChR subunit not thought to be a component of the levamisole-
sensitive neuromuscular nAChR was also amplified from Ascaris suum, but was 
amplified from head tissue rather than body wall muscle. A partial sequence of this 
subunit was present in the Ascaris EST database, which is surprising as generally only 
transcripts expressed at high levels are present in amongst such data. The 
bioinformatics analysis reported in chapter 3 also found a homologous sequence in the 
genome of Brugia malayi, which with the agreement of the annotators of the C. 
elegans nAChRs was designated acr-26. A remarkable feature of the acr-26 sequence 
is that it is clearly not homologous to any known C. elegans nAChR subunit, and is 
instead most similar to a type of nAChR subunit present in the pond snail Lymnaea 
stagnalis (van Nierop et al., 2006). Table 4.4 shows sequence similarity between 
Ascaris suum ACR-26 and other nAChR subunits present in the GenBank database. 
The closest match is an ACR-26 homologue from Haemonchus contortus which was 
also amplified in our laboratory (accesssion number EU006791; Thomas Walsh, 
unpublished). This finding discounts the possibility that the new subunit is specific to 
the clade III nematodes, and instead raises the intriguing possibility that it is specific 
to parasites from both clades V and III. If the search of similar nAChR subunits is 
restricted to human nAChR subunits, α7 and α10 are most similar to ACR-26 (37% 
 71
and 36% identity). The ACR-26 sequence is shown aligned against the a mammalian 
α7 sequence in Figure 4.3. The choice of α7 for the alignment is based on the fact that 
all the nAChR sequences more similar to ACR-26 represent extremely obscure 
subunits about which little is known; in addition to this, alignment against α7 shows 
that ACR-26 also appears to possess the ligand binding residues of the 
complementary binding loop D (see Figure 1.4 taken from Changeux & Taly 2008; 
also the alignment from Brejc et al., 2001) suggesting that it may be capable of 
forming a homomeric receptor. 
 
 
Table 4.4: Similarity between Ascaris suum ACR-26 and the 5 most similar 
nAChR subunits returned by a search of the GenBank database using the 
TBLASTN algorithm 
 
Species, nAChR subunit name (if not a 
clear homologue from another nematode 
species) 
Percent 
identity 
Accession number 
Brugia malayi (partial sequence) 
 
65% XM_001901191 
Haemonchus contortus 
 
70% EU006791 
Lymnaea stagnalis subunit G 
 
63% DQ167350 
Lymnaea stagnalis subunit D 
 
46% DQ167347 
Apis mellifera α-6 subunit 
 
39% DQ026035 
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Figure 4.3: Alignment of the novel nAChR subunit ACR-26 from Ascaris suum 
with the human neuronal α7 subunit  
 
The novel nAChR subunit ACR-26 from Ascaris suum has been aligned against the 
human α7 subunit to demonstrate similarities in the ligand binding residues. Like α7, 
ACR-26 has ligand binding residues belonging to both the principal binding loops 
characteristic of α subunits (coloured red, see Figure 1.4; annotated from Changeux & 
Taly, 2008, and Brejc et al., 2001), and residues from the complementary binding 
loop D (coloured turquoise, see Figure 1.4; annotated from Changeux & Taly, 2008, 
and Brejc et al., 2001). Also shown are residues confering cation specificity (coloured 
green; annotated from Corringer 2000, see Figure 1.5) and predicted transmembrane 
regions (yellow). 
 
ACR26           MATRRRELILLUFIHGVVDVVLADSSITDLSEIDGTATDEQKLLYHLLRQYEKAVRPVRN 
a7              ----------MRCSPGGVWLALAAS----LLHVSLQGEFQRKLYKELVKNYNPLERPVAN 
                          :    * * :.** *    * .:.  .  ::**  .*:::*:   *** * 
 
ACR26           ASHTVTVKLGMTMTNIFEMDEKNQVLTINVWLDQEWKDELLRWDPKEFGGIQSIRIPCDL 
a7              DSQPLTVYFSLSLLQIMDVDEKNQVLTTNIWLQMSWTDHYLQWNVSEYPGVKTVRFPDGQ 
                 *:.:** :.::: :*:::******** *:**: .*.*. *:*: .*: *::::*:* .  
 
ACR26           IWLPDIVLYNNADDYTAGYMRSRAMVFYDGTVFWPPPTQLRSTCKIDVTYFPFDSQHCAL 
a7              IWKPDILLYNSADERFDATFHTNVLVNSSGHCQYLPPGIFKSSCYIDVRWFPFDVQHCKL 
                ** ***:***.**:   . :::..:*  .*   : **  ::*:* *** :**** *** * 
 
ACR26           KFGSWTYHGFQVDITNRSDNVDLSNYVVSGEFDLVRVHQKRRVVKYTCCPEPYPDVTFFI 
a7              KFGSWSYGGWSLDLQMQ--EADISGYIPNGEWDLVGIPGKRSERFYECCKEPYPDVTFTV 
                *****:* *:.:*:  :  :.*:*.*: .**:*** :  **    * ** ******** : 
 
ACR26           HIRRKTLYYLYNVVFPCMMMSVLTLLVFLLPPDSGEKIALGITVLLAFSVFVLAIAEKMP 
a7              TMRRRTLYYGLNLLIPCVLISALALLVFLLPADSGEKISLGITVLLSLTVFMLLVAEIMP 
                 :**:****  *:::**:::*.*:*******.******:*******:::**:* :** ** 
 
ACR26           ETSDSMPLIGIYLTVVMAMTSVSVVMTVMVLNFHHRGPFNQAVPKWVHRLVLNRLRRALC 
a7              ATSDSVPLIAQYFASTMIIVGLSVVVTVIVLQYHYHDPDGGKMPKWTRVILLNWCAWFLR 
                 ****:***. *:: .* :..:***:**:**::*::.* .  :***.: ::**     *  
 
ACR26           MRLPYTG------WKDNGFCSANGMTKTISIGLAMDDFNVDSFEELDNQFLQMQETELVN 
a7              MKRPGEDKVRPACQHKQRRCSLASVEMSAVVPPPASNGNLLYIGFRGLDGVHCVPTPDSG 
                *: *  .       :.:  **  .:  :  :  . .: *:  :   . : ::   *   . 
 
ACR26           VDDAAALRKKKCRPNELHS-----------RLLKTLQVLIRRQEMEDLYQTLANEWRQVA 
a7              VVCGRMACSPTHDEHLLHGGQPPEGDPDLAKILEEVRYIANRFRCQDESEAVCSEWKFAA 
                *  .    . .   : **.           ::*: :: : .* . :*  :::..**: .* 
 
ACR26           QVIDRLLFWVFLVCTVIITLILLIIIPAVHRSMESDVFDESLYGLH 
a7              CVVDRLCLMAFSVFTIICTIGILMSAPNFVEAVSKDFA-------- 
                 *:*** : .* * *:* *: :*:  * . .::..*.          
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 4.4 Real-time PCR 
 
Real-time PCR was performed to ascertain whether relatively low expression levels of 
Ascaris suum unc-63 were causing difficulty in amplifying the full-length transcript. 
This technique also allowed a comparison to be made of expression levels of unc-38,  
unc-29 and unc-63 in tissue taken from Ascaris suum head and body wall. Head and 
muscle tissue were taken from 3 different individual nematodes and the RNA 
extracted. Reverse transcription reactions were performed on each batch of RNA, 
using the same amount of total RNA in the reaction each time. A reference gene 
expressed at the same levels in both head and muscle tissue was also amplified 
alongside the nAChR subunit genes to ensure the amplification in each reaction was 
comparable. Two replicates were performed for each amplification reaction from each 
batch of cDNA. Examples of amplification plots are shown in Figure 4.4. The real-
time PCR data is also reported as mean critical threshold (Ct) values in Table 4.5; 
critical threshold values indicate the number of PCR cycles necessary before the 
amplification of a transcript reaches the detection threshold. 
A comparison of relative abundance of the nAChR subunits in tissue taken from 
Ascaris suum head and body wall showed that there is very little difference in 
expression levels between these different regions of the nematode. This finding can 
only be preliminary however, as only very crude dissections were performed to obtain 
the tissue used this experiment. The head preparations would have contained 
pharyngeal tissue, sensory amphids, and the nerve ring in addition to muscle tissue; 
the body wall muscle would also have contained motorneurons and regions of the 
dorsal and ventral nerve cords. A more thorough comparison of nAChR subunit 
expression levels in different tissues would therefore require a more detailed 
dissection which separated the muscle from the nervous system and other tissues, and 
would require more fresh parasite tissue than was available during this investigation. 
When the relative abundance of the different nAChR subunits were compared, 
amplification of unc-63 (as shown by the Ct values in Table 4.5) occurred consistently 
later than amplification of unc-38 and unc-29. The Ct values suggest that unc-38 and 
unc-29 transcripts are perhaps equally adundant, whereas unc-63 is expressed at a 
slightly lower level. However, the relative expression level of unc-63 did not appear 
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low enough to be the major difficulty underlying the amplification of a full-length 
unc-63 transcript. 
 
Figure 4.4: Amplification plots showing the relative abundance of Ascaris suum 
unc-38, unc-29 and unc-63 in tissue taken from a)head and b)body wall. 
Amplification plots showing amplification of the reference gene β-tubulin (grey) and 
the nAChR subunit sequences unc-38 (blue), unc-29 (red) and unc-63 (green) by real-
time PCR. The Y-axis shows increasing fluorescence as more DNA is amplified. The 
X-axis shows the number of PCR cycles. The horizontal line near the bottom of the 
graph labelled Ct indicates the critical threshold above which amplification is 
detected. 
 
 
a) head 
Ct 
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b) body wall 
Ct 
 
 
Table 4.5: Critical threshold (Ct) values for real-time PCR amplification of 
reference gene β-tubulin and nAChR subunits unc-38, unc-29 and unc-63 from 
Ascaris suum head and body wall tissues 
 
 head  body wall 
β-tubulin 18.17 +/- 0.51 17.98 +/- 0.04 
 
unc-38 23.51 +/- 0.84 
 
23.19 +/- 0.83 
 
unc-29 24.16 +/- 0.80 
 
23.82 +/-1.01 
 
unc-63 25.94 +/- 0.76 
 
25.23 +/- 0.79 
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 4.5 Discussion 
 
In the course of this investigation, 3 full-length nAChR subunit sequences have been 
cloned from Ascaris suum cDNA; two of these were clear homologues of the C. 
elegans nAChR subunits unc-38 and unc-29, and are therefore good candidates for 
components of a levamisole-sensitive nAChR (Fleming et al., 1997). The additional 
full-length subunit, named acr-26, has no clear homologue in C. elegans but has been 
shown to be present in the parasites Brugia malayi and Haemonchus contortus, 
demonstrating that this subunit may be worthy of further investigation as a potential 
new anthelmintic target. The amplification of a partial sequence of unc-63 from 
Ascaris suum supports the findings described in chapter 3 that unc-63 appears to be 
present in other parasitic nematodes; this is further supported by the amplification of 
unc-63 from Ancylostoma caninum by McCarthy and colleagues. However, the failure 
to successfully extend the partial sequence to full length using either additional 
degenerate primers designed on conserved regions of other unc-63 sequences, or 
using a primer linked to the polyA tail of the mRNA during the reverse transcription, 
cannot be satisfactorily explained by the work presented here. Although unc-63 
appears to be expressed at lower levels than unc-38 and unc-29, it is clearly detectable 
by PCR. It is however a possibility that in Ascaris suum, the unc-63 transcript may be 
alternatively spliced, or simply truncated; such matters cannot be resolved until the 
genome sequence of Ascaris suum is completely sequenced, assembled and available 
to search.  
The amplification of cDNA sequence from Ascaris suum encoding these nAChR 
subunits provides a basis for further investigations into the molecular biology 
underlying the pharmacology of Ascaris suum nAChRs, in particular the basis of 
levamisole and pyrantel sensitivity. If Ascaris suum populations resistant to these 
drugs were to become available, the sequence of unc-38 and unc-29 could easily be 
checked for polymorphisms which may underly this differential drug sensitivity. In 
addition to this, if drug resistance was caused by a change in the expression levels of 
nAChR subunits, we have demonstrated that expression levels of unc-38, unc-29 and 
unc-63 from Ascaris suum can be quantified using real-time PCR. Such a difference 
in expression levels was found between hookworms resistant and susceptible to 
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pyrantel, and studies such as these can provide the basis for diagnostic assays to 
assess the level of drug resistance in a parasite population (Kopp et al., 2008; Walsh 
et al., 2007). 
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Chapter 5: Immunohistochemical localisation of 
Ascaris suum UNC-38, UNC-29 and UNC-63 
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5.1 Introduction: Ascaris muscle cells and the nematode 
neuromuscular junction 
 
The structure of muscle cells and the neuromuscular junction of nematodes differs 
markedly from that of vertebrates. A detailed study of the structure of Ascaris muscle 
cells and the neuromuscular junction was performed by Rosenbluth (1965), and is 
summarised in Figure 5.1. A typical muscle cell has 3 distinct regions: the contractile 
region, the "bag" or "belly" region of the cell containing the nucleus and glycogen 
stores, and a muscle arm which extends towards and contacts the nerve, forming the 
neuromuscular junction (Rosenbluth, 1965). It has since been shown, however, that 
the size of the bag region can be much reduced in some muscle cells, and that the 
number of muscle arms extending from a cell is also variable (del Castillo et al., 
1989; Stretton, 1976). In the region nearest to the nerve cord the muscle arms branch 
into very fine processes, which contact the muscle arm processes of adjacent muscle 
cells (Rosenbluth, 1965). Adjacent muscle cells have been shown to be electrically 
coupled via gap junctions connecting the muscle arm processes in this region, which 
is often termed the syncytium (de Bell et al., 1963). The presence of cholinergic 
receptors in Ascaris muscle tissue is well documented, as both muscle contractions 
and electrophysiological responses have been observed in response to cholinergic 
agonist application (Baldwin & Moyle, 1949; Colquhoun et al., 1991).  
In order to investigate whether the nAChR subunits UNC-38, UNC-29 and UNC-63 
were localised to the Ascaris suum the muscle cell membrane, polyclonal antibodies 
were raised against subunit-specific synthetic peptides and used to carry out indirect 
immunofluorescent labelling of Ascaris muscle cells. 
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Figure 5.1: The structure of the muscle cell and neuromuscular junction from 
Ascaris suum  (from Rosenbluth 1965) 
 
The muscle cell of Ascaris suum is divided into 3 distinct regions: the contractile 
region (F), the bag or "belly" of the cell containing the nucleus and glycogen stores 
(B), and the muscle cell arm (A) which branches into finer processes as it approaches 
the nerve cord (N) to form the neuromuscular junction. This differs from the 
vertebrate neuromuscular junction in that the muscle cells form processes which 
extend out to contact the nerve, rather than processes from the nerve cell extending 
out into the muscle. 
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5.2 Choice of peptides for antisera production and ELISA 
results 
 
In order to determine regions of the nAChR subunits suitable for use as peptides for 
the production of antisera, the translated N-terminal domain sequence of UNC-38, 
UNC-29 and UNC-63 was analysed using ProteAN software. The results of this are 
shown in Figure 5.2.1. The chosen peptides were predicted to be hydrophilic, 
antigenic, and had a high probability of being present on the surface of the protein in 
its folded conformation. The selected peptides were located at the extreme N-termini 
of the subunits just after the predicted signal peptide cleavage site, a strategy 
successfully used previously to raise antisera against nematode glutamate-gated 
chloride channels (Delany et al., 1998).  
The antisera were affinity purified, and enzyme-linked immunosorbent assays were 
performed to ensure that the antibodies had activity against the peptides used for 
antisera production. The results are shown in Figure 5.2.2, and confirm that the 
terminal antisera and affinity purified antibody solutions all show a greater titre of 
antibodies which react against the peptides used for antisera production than the pre-
immunw serum. The affinity purified antibody solutions also appeared to show less 
non-specific reactivity at greater dilutions than the terminal antiserum. The ELISA 
results were also used to determine an appropriate dilution of antibody for use in the 
subsequent indirect immunofluorescence procedures.  
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 Figure 5.2: ProteAn analysis of the sequences of Ascaris suum UNC-38, UNC-29 
and UNC-63  
 
 The ProteAn analysis software was used to predict the properties of the peptide 
sequence of the N-terminal domains of the Ascaris suum nAChR subunits. The 
relevant properties for use in antisera production are hydrophilicity, antigenicity and 
high surface probability, and these properties for the chosen peptide are outlined with 
a box. Below the ProteAn output the N-terminal subunit sequence is shown, with the 
predicted signal peptide removed, and the peptide chosen for antisera production 
highlighted. 
 
a) UNC-38 
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 b) UNC-29 
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DEQTCHLIFGSWTYNENEIKLEFEQAEWVDLSEYAPSSIWDVMDAPASLVNKRSRIEFQVRIRRKTLFY
TVVLIIPTVLMAFLSMAVFFLPTDSGEKMTLTI 
 
c) UNC-63 
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 Figure 5.3: ELISA results for antibodies against Ascaris suum UNC-38, UNC-29 
and UNC-63  
 
The ELISA results show a comparison of the reactivity of the terminal antisera, pre-
immune antisera and affinity purified antibodies against the peptides used for antisera 
production.  
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b) Antibody against UNC-29 
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c) Antibody against UNC-63 
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5.3 Indirect Immunofluorescence 
 
Muscle cells and cuticle-mounted nerve cords were prepared by collagenase digestion 
of fresh Ascaris suum adult females as described in section 2.4.4 (Johnson & Stretton, 
1985). The material was then fixed and sequentially incubated with primary and 
secondary antibody solutions as descibed in section 2.4.5 (Brownlee et al., 1993). 
Negative controls were used to demonstrate that the antibody labelling was specific to 
the nAChR subunits; these are shown in Figure 5.3.1. The negative controls were pre-
absorbed primary antibody, normal goat IgG, and secondary antiserum alone. The 
negative controls all showed only very low levels of immunofluorescence consistent 
with very little non-specific antibody labelling. Unfortunately the microscope used 
did not have a phase-contrast feature which would have allowed clear images of the 
specimens to be obtained using visible light.  
Initially, Ascaris suum muscle cells, and strips of cuticle with attached nerve cord, 
were incubated with antibody against UNC-38. The purpose of this was to investigate 
whether the nAChRs containing this subunit were neuromuscular or neuronal. The 
results of this are shown in Figure 5.3.2. UNC-38 is clearly localised to the muscle 
cell membrane, and is present over the entire muscle cell surface. The neuronal tissue 
itself was not labelled with the antibody against UNC-38, but the nerve-cord 
preparation did reveal details of the muscle arm processes contacting the nerve cord to 
form the neuromuscular junctions. 
Muscle cells were then incubated with primary antibodies against both UNC-38 and 
UNC-29, followed by secondary antibodies conjugated to different fluorescent labels, 
to ascertain whether UNC-38 and UNC-29 co-localised. The results of this are shown 
in Figure 5.3.3. Both UNC-38 and UNC-29 were localised to the muscle cell 
membrane, and clearly co-localised, especially in the region of the muscle cell arm. 
At high magnification, the co-localised fluorescence has a punctate appearance, which 
may represent receptor clusters in the distal region of the muscle cell arm. 
Finally, muscle cells were incubated with antibodies against UNC-63, the results of 
which are shown in Figure 5.3.4. UNC-63 is also clearly localised to the muscle cell 
arms of Ascaris suum. However, attempts to perform co-localisation experiments 
using antibodies against UNC-63 and UNC-29 together were unsuccessful, with only 
the UNC-29 labelling being visible (results not shown). Possible reasons for this are 
discussed in section 5.4. 
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 Figure 5.4: Confocal microscope images of negative controls for indirect 
immunofluorescent labelling of Ascaris suum muscle cells 
 
In the absence of specific primary antibody, very little fluorescence was observed on 
muscle cells after incubation with a 1:200 dilution of FITC conjugated secondary 
antiserum. 
 
a) Normal goat IgG   b) Pre-absorbed primary antibody 
 
 
 
c) Secondary antiserum only 
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Figure 5.5: Indirect immunofluorescent labelling of Ascaris suum UNC-38  
 
Confocal microscope images showing indirect immunofluorescent labelling of 
Ascaris suum muscle with primary antibody against UNC-38 (affinity purified from 
goat serum, used at 1:100 dilution) and FITC conjugated secondary antibody (rabbit 
anti-goat, used at 1:200 dilution). a) Whole muscle cell, showing UNC-38 localised to 
the cell membrane over the entire cell surface. Arrow A indicates the muscle cell arm, 
B the bag region of the cell, and C the contractile region. b) UNC-38 localised to the 
muscle arms (indicated by arrows) where contact with the nerve cord is made to form 
the neuromuscular junction. No labelling of the nerve cord itself was observed.  
 
a) 
A 
B 
C 
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Figure 5.6: Co-localisation of Ascaris suum UNC-38 and UNC-29 on muscle cell 
membranes  
 
NC-38 and UU NC-29 are both localised to the Ascaris suum muscle cell membrane, 
100 
)    b)    c) 
and can be seen to co-localise, particularly on the muscle cell arm. This figure 
contains three sets of images showing this at progressive levels of magnification.  
a) left panel: UNC-38 primary antibody (affinity purified from goat serum, 1:
dilution) and FITC (green) conjugated secondary antibody (rabbit anti-goat, 1:200 
dilution). b) central panel: UNC-29 primary antibody (affinity purified from rabbit 
serum, 1:100 dilution) and alexafluor 594 (red) conjugated secondary antibody (goat 
anti-rabbit, 1:200 dilution). c) right panel: co-localisation of UNC-38 and UNC-29 
(yellow). 
 
a
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Figure 5.7: Indirect immunofluorescent labelling of Ascaris suum UNC-63 
 
Indirect immunofluorescent labelling of the Ascaris suum muscle cell arm using 
primary antibody against UNC-63 (affinity purified from goat serum, 1:100 dilution) 
and FITC conjugated secondary antibody (rabbit anti-goat, 1:200 dilution). A 
greyscale image was obtained, and is shown at two different magnifications. 
 
 
 
 
 
 92
 5.4 Discussion 
 
The strategy of raising antisera against short N-terminal subunit-specific peptides 
from the nAChR subunits UNC-38, UNC-29 and UNC-63 appears to have been 
successful; the ELISA results confirm that in all cases, immunisation resulted in the 
production of antibodies directed against the peptides. The negative controls carried 
out alongside the immunofluorescent labelling did not show any fluorescent labelling 
in the absence of specific primary antibody, and non-specific IgG did not bind to the 
Ascaris suum muscle cells. However, the absolute specificity of these antibodies for 
the target nAChR subunit can not be taken for granted; in the case of mammalian 
nAChRs it has been demonstrated that antibodies against α7 also recognise other 
roteins, and will label tissue from the α7-/- mouse (Jones & Wonnacott, 2005). In the 
ase of a parasitic nematode for which transgenic techniques are unavailable, it is very 
ifficult to confirm antibody specificity in such a manner. The specificity of our 
antibodies for the target nAChR has to some extent been confirmed by our 
 State University, who were able to partially inhibit levamisole-
duced contractions of Ascaris suum muscle by prior incubation with the antibodies 
p
c
d
collaborators at Iowa
in
directed against UNC-38 and UNC-29 (Alan Robertson, personal communication). 
No such effect was seen using the antibody directed against UNC-63, and it is 
interesting that this is the antibody for which we failed to achieve co-localisation with 
the antibody directed against UNC-29. This could suggest that UNC-63 is perhaps not 
a component of either the UNC-29 containing nAChR or the levamisole-receptor. 
However, any negative results obtained by our collaborators may also be explained by 
the difficulties involved in sufficiently permeabilising the Ascaris muscle tissue to 
allow antibody penetration while still retaining enough integrity that the muscle will 
contract (Alan Robertson, personal communication). Similarly, our failure to 
demonstrate co-localisation may result from some interaction between the UNC-63 
and UNC-29 antibodies, or may have been due to the presence of less UNC-63 
protein than UNC-29, which might have led to the stronger fluorescence from UNC-
29 masking weaker fluorescence from UNC-63. Unfortunately it was not possible to 
obtain sufficient fresh Ascaris suum specimens to make repeated attempts to 
demonstrate co-localisation of UNC-63 and UNC-29; indeed, a shortage of fresh, live 
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Ascaris specimens limited the number of times any of the immunofluorescence 
experiments could be carried out to 3 replicates of the UNC-38 and UNC-29 labelling, 
and two replicates of the UNC-63 labelling. 
The results shown here demonstrate that Ascaris suum UNC-38 and UNC-29 are 
localised to the muscle cell membrane, and clearly co-localise. This is consistent with 
the proposed role for UNC-38 and UNC-29 as components of the same levamisole-
sensitive receptor present at the C. elegans neuromuscular junction (Fleming et al., 
1997). The distribution of receptors over the whole surface of the Ascaris suum 
muscle cell differs from the receptor distribution in C. elegans, where the receptors 
are confined to clusters at the neuromuscular junction (Qian et al., 2008). However, 
the presence of nAChRs on the bag region of the Ascaris suum muscle cell is well 
described, and single-channel electrophysiological recordings of Ascaris cholinergic 
receptors are routinely performed using the bag region of the muscle cell (Brading & 
Caldwell, 1971; Pennington & Martin, 1990). It is therefore likely that the distribution 
of fluorescent labelling observed on the Ascaris muscle cell does indeed represent the 
distribution of actual nAChRs. 
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 Chapter 6: Electrophysiology 
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6.1 Introduction 
 
The oocytes of the African clawed frog Xenopus laevis have been used for the 
expression of exogenous proteins since the 1970's. Initially it was discovered that 
injection of mRNA encoding globins into oocytes resulted in translation of the 
exogenous protein (Gurdon et al., 1974). Subsequently, it was demonstrated that 
injection of mRNA or cDNA extracted from vertebrate brain resulted in the 
expression of neuronal membrane proteins and receptors (Ballivet et al., 1988; 
Tomaselli et al., 1989). Of particular relevance to the work presented here, it was 
shown that injection of Torpedo electric organ mRNA into Xenopus oocytes resulted 
in the production of functional nAChRs (Sumikawa et al., 1984). Other studies 
showed that cloning, in vitro transcription and oocyte injection of Torpedo nAChR 
subunits also produced functional recombinant nAChRs (Mishina et al., 1984). The 
Xenopus oocyte system therefore has a long established history as a useful tool for 
heterologous expression of ligand-gated ion channels. 
The most widely used electrophysiological technique employed to study exogenous 
receptors and channels expressed in Xenopus oocytes is two-electrode voltage clamp. 
The principal of this technique is to control the cell membrane potential in order to 
allow measurements of current to be made; initially this procedure was developed to 
study the giant axons of squid (Hodgkin et al., 1952; Marmont, 1949). The large size 
of the Xenopus oocyte makes it particularly amenable to two-electrode voltage-clamp 
experiments. A voltage electrode inserted through the cell membrane holds the 
membrane potential constant, while a second intracellular electrode applies the 
necessary current to maintain this membrane potential. The current is applied and the 
holding potential maintained by a feedback amplifier connected to the electrodes 
(summarised in Hille 2001). The changes in current needed to maintain the membrane 
potential correspond to changes in ion flow through the membrane, which occur when 
the ion channels under investigation open. These changes in current are converted to a 
digital signal and recorded by a computer equipped with appropriate software. 
The Xenopus oocyte expression system and the two-electrode voltage clamp 
technique have been used to study ligand-gated ion channels of both vertebrates and 
invertebrates. The system allows the proposed function of cloned cDNAs showing 
sequence homology with other LGICs to be confirmed (Schofield et al., 1987). 
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The LGICs of the model organisms C. elegans and Drosophila melanogaster have 
been extensively studied by expression in Xenopus oocytes (Bianchi & Driscoll, 2006; 
Buckingham et al., 2006). The glutamate-gated chloride channels of C. elegans have 
been expressed in Xenopus oocytes and used to confirm the mode of action of the 
avermectin anthelmintics (Arena et al., 1992). The Drosophila GABA receptor RDL 
expresses most efficiently and is a useful screen for the ability of potential insecticide 
resistance mutations to alter the pharmacology of the receptor (ffrench-Constant & 
Rocheleau, 1993; Le Goff et al., 2005). 
The nicotinic acetylcholine receptors of invertebrates have also been expressed in 
Xenopus oocytes for two-electrode voltage clamp experiments, though perhaps with 
less success than the ligand-gated chloride channels. Typically, currents induced by 
agonist application are much smaller, though this can in some cases be improved by 
co-expression of a relevant accessory protein (Halevi et al., 2002). 
In the case of heteromeric nAChRs, expression can be impaired by the lack of 
appropriate complementary subunits, though this can sometimes be overcome by the 
construction of chimaeras or the co-expression of subunits from a different species 
(Ihara et al., 2003; Shimomura et al., 2005). Despite these potential difficulties, the 
Xenopus oocyte expression system remains a useful tool for expressing invertebrate 
nicotinic acetylcholine receptors for two-electrode voltage clamp. An example of 
particular relevance to the work presented here is the successful expression of 
proposed components of the C. elegans levamisole receptor UNC-38, UNC-29 and 
LEV-1, which formed a functional levamisole-sensitive nAChR (Fleming et al., 
1997). 
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6.2: Initial experiments to co-express Ascaris unc-38 and 
unc-29 
 
Preliminary experiments were performed to demonstrate that Ascaris unc-38 and unc-
29 did indeed co-express to form a heteromeric receptor. Oocytes were injected either 
with 25ng of Ascaris unc-38 cRNA, 25ng of Ascaris unc-29 cRNA, or 25ng Ascaris 
unc-38+25ng Ascaris unc-29 cRNA. All injection volumes were adjusted to 50nl 
using nuclease-free water. The results of this are shown in Figure 6.1, and clearly 
demonstrate that both Ascaris unc-38 and unc-29 are required to produce a functional 
nAChR which responds to ACh. The response to 100µM ACh was ~600-800nA, 
varying between different oocytes. 
Preliminary pharmacological experiments were then performed to discover which 
agonists the heterologously expressed Ascaris nAChR responded to, and to ensure 
that such responses could be blocked with an appropriate antagonist to confirm a 
genuine  nAChR response. The agonists used were nicotine, ACh and levamisole; it 
has been demonstrated that in C. elegans, UNC-38 and UNC-29 are components of 
the levamisole-sensitive nAChR (Fleming et al., 1997). The antagonist chosen was 
mecamylamine; this is a broad-spectrum non-competitive antagonist of nAChRs, and 
has additionally been shown to inhibit ACh-induced contractions and currents in 
native Ascaris muscle preparations (Colquhoun et al., 1991; Natoff, 1969). The 
results are shown in Figure 6.2. The receptors composed of Ascaris unc-38 and unc-
29 clearly respond to 100µM concentrations of acetylcholine, nicotine and 
levamisole; the response to levamisole appeared slightly larger than the response to 
ACh, which was in turn slightly larger than the response to nicotine. The responses to 
all these agonists can be fully blocked by application of 10µM mecamylamine, and 
the response recovers when the mecamylamine is washed off. The response to 
nicotine, and the blockade by mecamylamine, confirm that the ACh response is 
nicotinic in nature, rather than muscarinic. The relatively large response to levamisole 
confirms that in Ascaris suum, UNC-38 and UNC-29 are components of a levamisole-
sensitive nAChR, as they are in C. elegans. 
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Figure 6.1: Both Ascaris unc-38 and unc-29 are required to form a functional 
nAChR  
 
Both UNC-38 and UNC-29 are required to produce a functional nAChR. Lefthand 
trace: there is no response to application of ACh from an oocyte injected with unc-38 
RNA alone. Centre trace: There is no response to application of ACh from an oocyte 
injected with unc-29 RNA alone. Righthand trace: Application of 100µM ACh to an 
oocyte injected with an equimolar ratio of unc-38 and unc-29 RNA produces a ~600-
800nA response. 
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Figure 6.2: The nAChRs composed of UNC-38 and UNC-29 are sensitive to the 
agonists ACh, levamisole and nicotine, and can be reversibly blocked by the 
antagonist mecamylamine. 
 
Left panels: co-expression of unc-38 and unc-29 produces nAChRs which respond to 
application of 100µM acetylcholine (top), levamisole (centre) and nicotine (bottom). 
Centre panels: All these responses can be blocked by application of 10µM 
mecamylamine. Right panels: All responses recover after the antagonist has been 
washed off. 
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Dose-response experiments were carried out using oocytes injected with equimolar 
ratios of Ascaris unc-38 and unc-29, and the agonists levamisole, ACh, and nicotine. 
The recorded responses from each oocyte were normalised to the response to 100µM 
ACh, and were analysed using GraphPad Prism software. Sigmoidal dose-response 
curves were fitted to each dataset, and the EC50 and Hill slope coefficients obtained 
from the curves. These graphs are shown in Figure 6.3, and the EC50 values and Hill 
coefficients are summarised in Table 6.1. The order of agonist efficacy appears to be 
levamisole>ACh>nicotine, though the EC50 values suggest these compounds show 
similar potency. It is possible that if the data were reanalysed to measure area under 
the peak rather than peak height, the results may show levamisole to be more potent, 
as application of this drug produced broader peaks. This is consistent with 
observations from native Ascaris muscle (Colquhoun et al., 1991; Harrow & Gration, 
1984). However, studies of native muscle will always contain recordings from a 
mixed population of receptors with different pharmacological properties; the graphs 
presented here, with their very shallow slope and a large variation in the 
measurements of Hill slope, may also be indicative of a mixed receptor population. 
Indeed, the pentameric nature of the nAChR itself suggests that injecting equimolar 
concentrations of cRNA for 2 subunits is unlikely to produce a homogenous 
population; early experiments expressing α4β2 in Xenopus oocytes produced mixed 
receptor populations resulting in rather flattened dose response curves with shallow 
slopes (Zwart & Vijverberg, 1998). These curves were interpreted as resulting from 
receptors with different stoichiometries having different pharmacological properties, 
and prompted experiments using different ratios of α4:β2 RNA to influence the 
receptor stoichiometry (Zwart & Vijverberg, 1998). Knowledge of this work 
suggested that further experiments are required to investigate whether the 
pharmacology of recombinant Ascaris nAChRs is affected by stoichiometry. 
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Figure 6.3: Dose-response relationships for the agonists levamisole, ACh and 
nicotine applied to oocytes injected with equimolar concentrations of Ascaris 
unc-38 and unc-29 cRNA 
 
 All responses were normalised to the response of each oocyte to 100µM ACh, and 
sigmoidal dose-response curves were fitted to the data using GraphPad Prism. N=3 
(where N is batches of oocytes) and n=6 (where n is number of individual oocytes) 
minimum for each data point. The order of agonist efficacy is levamisole > ACh > 
nicotine. 
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Table 6.1:  EC50 values and Hill slope values for oocytes injected with equimolar 
concentrations of Ascaris unc-38 and unc-29 cRNA 
 
Agonist ACh Levamisole Nicotine 
EC50 1.07e-005 1.68e-005 1.62e-005 
     95% confidence 
intervals of EC50
5.19e-006 to  
2.21e-005 
5.12e-006 to 
 5.49e-005 
5.84e-006 to  
4.48e-005 
Hill slope 0.625   0.635 0.774 
95% confidence 
intervals of Hill 
slope 
 0.353 to 0.897
   
0.181 to 1.09 0.137 to 1.41 
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6.3 Experiments using oocytes injected with 1:5 and 5:1 
ratios of Ascaris unc-38 and unc29 cRNA 
 
Oocytes were injected with Ascaris unc-38 + unc-29 cRNA in the ratios 1:5 and 5:1 
unc-38:unc-29. The total amount of RNA injected was kept constant at 50ng per 
oocyte, in an injection volume of 50nl. It was hoped that this would drive the 
stoichiometry of the expressed receptors to either 3:2 UNC-38:UNC-29 or 2:3 UNC-
38:UNC-29, to allow any difference in pharmacology between the two types to be 
further investigated. Although potentially receptors with a 4:1 or 1:4 stoichiometry 
could also be generated, it has previously been demonstrated by transfection of cells 
with α4 and β2 cDNA that the stoichiometry of such heteromeric receptors composed 
of just 2 subunits is 3:2 or 2:3, and that adjusting the subunit cDNA ratios drove the 
receptors to one stoichiometry or the other without introducing new combinations 
(Nelson et al., 2003). Preliminary experiments suggested that the 1:5 and 5:1 RNA 
ratios were optimal for this experiment; although studies of the human α4β2 receptor 
have used 10:1 or 9:1 ratios to drive changes in receptor stoichiometry (Moroni et al., 
2006; Nelson et al., 2003; Zwart & Vijverberg, 1998). 1:10 and 10:1 ratios of Ascaris 
unc-38:unc-29 RNA either did not produce functional receptors, or resulted in very 
low expression levels where the maximal current was <20nA.  
Dose-response experiments using the agonists levamisole and nicotine were carried 
out on the receptors expressed from injection of the different RNA ratios. Maximal 
responses from oocytes injected with the 1:5 ratio were ~300-400nA; for the 5:1 ratio,  
~100-200nA. The responses from each oocyte were normalised to the response to 
100µM ACh, and were again analysed using GraphPad Prism as described in Results 
section 1. Dose response relationships and examples of electrophysiology traces for 
oocytes injected with a 1:5 ratio of unc-38:unc-29 RNA are shown in Figure 6.4. Dose 
response relationships and examples of electrophysiology traces for oocytes injected 
with a 5:1 ratio of unc-38:unc-29 RNA are shown in Figure 6.5. The EC50 and Hill 
slope values are presented in Table 6.2. 
Changing the stoichiometry of the Ascaris nAChR by using different RNA ratios 
clearly has an effect on the pharmacology. The 1:5 ratio produces a receptor 
population which is more sensitive to levamisole, whereas nicotine is only a partial 
agonist . In contrast to this, the 5:1 ratio produces a receptor population which is most 
sensitive to nicotine, whereas levamisole is only a partial agonist. It cannot be inferred 
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from the data collected here whether the partial activity of the less efficacious 
compound resulted from a true partial agonism of an almost homogeneous receptor 
population, or from full agonist activity at a sub-population of receptors with the 
opposite stoichiometry to that of the majority in a heterogeneous population. Once 
again, the relatively shallow slope of the graphs may suggest a mixed receptor 
population, but attempts to fit two separate curves to each dataset using Graphpad 
Prism were unsuccessful. 
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 Figure 6.4: Dose-response relationships for levamisole and nicotine for oocytes 
injected with a 1:5 ratio of unc-38:unc-29 cRNA 
 
A 1:5 ratio of unc-38:unc-29 RNA produces a receptor population most sensitive to 
levamisole and less sensitive to nicotine. a) Dose-response relationships for 
levamisole and nicotine from oocytes injected with a 1:5 ratio of unc-38:unc-29. All 
data was normalised to the response to 100µM ACh for each individual oocyte. N=3 
n=6 minimum for each data point, where N is the number of batches of oocytes, and n 
is the number of individual oocytes. Sigmoidal dose-response curves were fitted using 
GraphPad Prism. b) Example electrophysiology traces from an oocyte injected with a 
1:5 ratio of unc-38: unc-29 in respose to the application of levamisole (upper trace) 
and nicotine (lower trace). The currents evoked by levamisole application are larger 
than those produced by nicotine application. Agonist application is indicated by a bar 
above the trace. Agonist concentrations were applied in the order 1mM, 100µM, 
10µM, 1µM then 100nM. 
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b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 106
 Figure 6.5: Dose-response relationships for levamisole and nicotine for oocytes 
injected with a 5:1 ratio of unc-38:unc-29 cRNA 
 
A 5:1 ratio of unc-38:unc-29 RNA produces a receptor population most sensitive to 
nicotine and less sensitive to levamisole. a) Dose-response relationships for 
levamisole and nicotine from oocytes injected with a 5:1 ratio of unc-38:unc-29. All 
data was normalised to the response to 100µM ACh for each individual oocyte. N=3 
n=6 minimum for each data point. Sigmoidal dose-response curves were fitted using 
GraphPad Prism. b) Example electrophysiology traces from an oocyte injected with a 
5:1 ratio of unc-38: unc-29 in respose to the application of levamisole (upper trace) 
and nicotine (lower trace). The currents evoked by levamisole application are larger 
than those produced by nicotine application. Agonist application is indicated by a bar 
above the trace. Agonist concentrations were applied in the order 1mM, 100µM, 
10µM, 1µM then 100nM. 
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 b) 
 
 
Table 6.2: EC50 and Hill slope values for ooctes injectedwith 1:5 and 5:1 ratios of 
Ascaris unc-38:unc-29 RNA 
 
RNA Ratio 
(unc-38:unc-
29) 
1:5 1:5 5:1 5:1 
 
Agonist Levamisole Nicotine Levamisole Nicotine 
EC50 7.74e-006 1.33e-006 4.15e-005  6.93e-006 
95% 
confidence 
interval EC50
9.53e-007 to 
6.29e-005  
1.65e-008 to 
1.06e-004 
7.85e-015 to 
219000  
8.49e-008 to 
5.66e-004 
Hill slope 0.314 0.240 0.161  0.247 
95% 
confidence 
interval of Hill 
slope 
0.201 to 0.427  0.0673 to 
0.412 
-0.0672 to 
0.389  
0.107 to 0.388 
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Although changing the receptor pharmacology by adjusting the stoichiometry is well 
described for the mammalian α4β2 receptor (Moroni & Bermudez, 2006; Moroni et 
al., 2006; Nelson et al., 2003), this has not previously been demonstrated in 
invertebrates. The striking difference in sensitivity to levamisole and nicotine 
observed between receptor populations driven to different stoichiometry also raised 
the possibility that two of the observed pharmacological subtypes found in native 
Ascaris muscle (the L- and N- subtypes) could in fact be generated using just these 
two nAChR subunits, UNC-38 and UNC-29 (Levandoski et al., 2005). It was 
therefore necessary to test this hypothesis using different agonist compounds known 
to be specific for these different pharmacological nAChR subtypes. 
 
6.4 Further pharmacological studies on oocytes injected with 
1:5 and 5:1 ratios of Ascaris unc-38 and unc29 cRNA 
 
Oocytes were again injected with 1:5 or 5:1 ratios of Ascaris unc-38:unc-29 cRNA, to 
produce receptor populations with predominantly 2:3 or 3:2 UNC-38:UNC-29 
stoichiometry. Of the available agonist compounds, pyrantel and oxantel were chosen 
for comparative pharmacology because in addition to their respective specificity for 
the L- and N-subtypes (Martin et al., 2004; Qian et al., 2006; Robertson et al., 1994) 
they are anthelmintic drugs of medical and veterinary relevance. Dose-response 
experiments were performed on the oocytes injected with 1:5 and 5:1 ratios of Ascaris 
unc-38:unc-29 cRNA using pyrantel and oxantel. The action of these compounds is 
more  complex than the simple agonist properties of nicotine, levamisole and ACh; 
pyrantel and oxantel are known to be agonists of the native Ascaris nAChRs at low 
concentrations, but cause open channel block at higher concentrations,  producing an 
asymmetric bell-shaped dose-response relationship (Dale & Martin, 1995; Harrow & 
Gration, 1984). The oocytes injected with a 1:5 ratio of Ascaris unc-38:unc29 cRNA 
were much more sensitive to pyrantel, showing very little response to the application 
of oxantel. The responses for this experiment were all normalised to the maximal 
response to pyrantel, which occurred at a concentration of 1µM. Dose-response 
relationships for pyrantel and oxantel from oocytes injected with a 1:5 ratio of Ascaris 
unc-38:unc-29 cRNA are shown in Figure 6.6a; examples of the electrophysiology 
traces obtained from these experiments are shown in Figure 6.6b. The oocytes 
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injected with a 5:1 ratio of Ascaris unc-38:unc29 cRNA were much more sensitive to 
oxantel, showing very little response to the application of pyrantel. The responses for 
this experiment were therefore all normalised to the maximal response to oxantel, 
which occurred at a concentration of 10µM. Dose-response relationships for pyrantel 
and oxantel from oocytes injected with a 1:5 ratio of Ascaris unc-38:unc-29 cRNA are 
shown in Figure 6.7a; examples of the electrophysiology traces obtained from these 
experiments are shown in Figure 6.7b. The data were initially plotted simply as points 
on graphs of the logarithm of drug concentration against the normalised response; 
attempts to utilise an appropriate equation to fit a curve with two components to the 
data (Moroni et al., 2008; Whiteaker et al., 1998) were unsuccessful, probably due to 
the steepness of the slopes. In order to obtain estimates of the EC50 and IC50 values for 
the actions of pyrantel and oxantel on the expressed Ascaris nAChRs, the data was 
split into agonist and antagonist components, which were analysed separately in 
Graphpad Prism as described in section 6.2. These graphs are shown in Figure 6.8 and 
the EC50, IC50 and Hill slope values are summarised in Table 6.3. 
The steepness of the graphs, which did not flatten as they approached Imax, caused 
sigmoidal dose-response relationships to be a poor fit for the data. It is likely that if 
the agonist and antagonist components did not intersect, then the top of the graphs 
would exceed the observed Imax. This would mean that the potential maximal current 
would greatly exceed the maximal response to acetylcholine; this could perhaps be 
explained by the described action of oxantel as an allosteric modulator (Raymond et 
al., 2000), or one could speculate that pyrantel and oxantel act as super-agonists, in a 
similar manner to the neonicotinoid insecticide clothianidin (Ihara et al., 2004). 
Unfortunately it was beyond the scope of this particular experiment to further separate 
the agonist and antagonist components of the responses to pyrantel and oxantel. 
However, the data clearly shows that oocytes injected with a 1:5 ratio of Ascaris unc-
38:unc-29 cRNA are much more sensitive to pyrantel, while the 5:1 ratio produces 
receptors much more sensitive to oxantel. This supports the hypothesis that the 1:5 
ratio may induce expression of the L-type nAChR observed in Ascaris suum muscle, 
most sensitive to levamisole and pyrantel; while the 5:1 ratio may induce expression 
of the N-subtype nAChR, most sensitive to nicotine and oxantel.  
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Figure 6.6: Dose-response relationships for pyrantel and oxantel applied to 
oocytes injected with a 1:5 ratio of Ascaris unc-38:unc-29 cRNA.  
 
A 1:5 ratio of unc-38:unc-29 RNA produces a receptor population most sensitive to 
pyrantel and much less sensitive to oxantel. a) Dose-response relationships for 
pyrantel and oxantel applied to oocytes injected with a 1:5 ratio of Ascaris unc-
38:unc-29. All data was normalised to the response to 1µM pyrantel for each 
individual oocyte. N=3 n=6 minimum for each data point. b) Example 
electrophysiology traces from an oocyte injected with a 1:5 ratio of unc-38: unc-29 in 
respose to the application of pyrantel (upper trace) and oxantel (lower trace). The 
currents evoked by pyrantel application were much larger  than those produced by 
oxantel application. Agonist application is indicated by a bar above the trace. Pyrantel 
concentrations were applied in the order 100µM, 10µM, 3µM, 1µM, 600nM, 100nM, 
10nM. Oxantel concentrations were applied in the order 100µM, 10µM, 1µM, 100nM, 
10nM. 
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Figure 6.7: Dose-response relationship for oxantel and pyrantel applied to 
oocytes injected with a 5:1 ratio of Ascaris unc-38:unc-29 cRNA.  
 
A 5:1 ratio of Ascaris unc-38:unc-29 cRNA produces a receptor population most 
sensitive to oxantel and much less sensitive to pyrantel. a) Dose-response 
relationships for pyrantel and oxantel applied to oocytes injected with a 5:1 ratio of 
Ascaris unc-38:unc-29. All data was normalised to the response to 10µM oxantel for 
each individual oocyte. N=3 n=6 minimum for each data point. b) Example 
electrophysiology traces from an oocyte injected with a 5:1 ratio of unc-38: unc-29 in 
respose to the application of oxantel (upper trace) and pyrantel (lower trace). The 
currents evoked by oxantel application were much larger  than those produced by 
pyrantel application. Agonist application is indicated by a bar above the trace. Oxantel 
concentrations were applied in the order100nM, 1µM, 6µM, 10µM, 60µM, 100µM, 
600µM. Pyrantel concentrations were applied in the order 100µM, 10µM, 1µM, 
100nM, 10nM. 
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Figure 6.8: Sigmoidal curves fitted to separate agonist and antagonist 
components of dose-response data for pyrantel and oxantel  
 
GraphPad Prism was used to fit sigmoidal dose response curves to the separate 
agonist and antagonist components of the normalised dose-response data for pyrantel  
on oocytes injected with the 1:5 ratio of Ascaris unc-38:unc-29 cRNA (panels a and 
b) and for oxantel on oocytes injected with a 5:1 ratio of Ascaris unc-38:unc-29 
cRNA (panels c and d). 
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Table 6.3: EC50, IC50 and Hill slope values for oxantel and pyrantel on oocytes 
injected with a 1:5 and 5:1 ratio of Ascaris unc-38:unc-29 RNA 
 
Data obtained from fitting separate dose-response curves to agomist and antagonist 
components of normalised dose-response data using GraphPad Prism. Values are 
shown to 3 significant figures. 
 
 
RNA ratio (unc-38:unc-
29) 
 
1:5 5:1 
Compound 
 
Pyrantel Oxantel 
EC50 
 
3.95e-007 4.06e-006 
95% confidence interval 
EC50 
 
1.73e-007 to 9.01e-007 3.03e-008 to 5.43e-004 
Hill slope (agonist 
component) 
 
1.31 0.397 
95% confidence interval 
Hill slope 
 
0.484 to 2.14 -0.00191 to 0.794 
IC50 
 
2.17e-006 7.86e-005 
95% confidence interval 
IC50 
 
9.55e-007 to 4.95e-006 4.06e-005 to 1.52e-004 
Hill slope (antagonist 
component) 
 
-1.64 -0.843 
95% confidence interval 
Hill slope 
 
-2.99 to -0.285 -1.19 to -0.494 
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 6.5 Discussion 
 
The heterologous expression of functional levamisole-sensitive nAChRs using the 
Ascaris suum homologues of unc-38 and unc-29 confirms that in Ascaris, as in C. 
elegans, these subunits are likely to be components of the native levamisole-sensitive 
nAChR (Fleming et al., 1997). However, in C. elegans, it has been reported that 3 
other nAChR subunits are necessary for the levamisole response: unc-63, lev-1, and 
lev-8 (Culetto et al., 2004; Fleming et al., 1997; Towers et al., 2005). We have shown 
using a bioinformatics approach and the genome of Brugia malayi and a parasite 
closely related to Ascaris suum that lev-1 and lev-8 are apparently absent in this group 
of nematodes; however unc-63 is apparently present and well-conserved. The 
functional significance of unc-63 in Ascaris is currently unknown, and further 
experiments, where Ascaris unc-63 would be co-expressed with unc-38 and unc-29, 
are necessary to elucidate what effect this subunit would have on receptor 
pharmacology. It is possible that the third pharmacological nAChR subtype described 
from Ascaris, the B-subtype, most sensitive to bephenium, may contain the UNC-63 
subunit (Qian et al., 2006; Robertson et al., 2002). 
If the pharmacology of Ascaris nAChRs can be altered simply by generating different 
combinations of two subunits, this may help to explain how sufficient 
pharmacological and neurological complexity can be found in parasites with 
remarkably few nAChR genes compared to the model nematode C. elegans. 
Pharmacological diversity generated by alternate stoichiometries have not previously 
been described from invertebrates, but are well described for heterologous expression 
of the mammalian neuronal nAChR subunits α4 and β2 (Nelson et al., 2003; Zwart & 
Vijverberg, 1998). Receptors with the stoichiometry  (α4)3(β2)2 have lower agonist 
affinity and a different pharmacological profile to receptors with the stoichiometry 
(α4)2(β2)3, and addition of an accessory subunit to give (for example) an 
(α4)2(β2)2(α5) combination confers additional pharmacological differences (Kuryatov 
et al., 2008; Moroni et al., 2006). In extrapolating the α4β2 model to interpret the 
results presented here, we may speculate that in Ascaris the 3 pharmacological 
subtypes may have the stoichiometry (UNC-38)2(UNC-29)3, (UNC-38)3(UNC-29)2, 
and (UNC-38)2(UNC-29)2(UNC-63), where (UNC-38)2(UNC-29)3 constitutes the L-
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subtype, (UNC-38)3(UNC-29)2 forms the N-subtype, and addition of UNC-63 as an 
accessory subunit may potentially create the B-subtype. Further work is necessary to 
confirm or refute this hypothesis: the stoichiometry of the receptors expressed here is 
only inferred, and experiments where receptor stoichiometry is more clearly defined 
would use concatamers composed of Ascaris unc-38 and unc-29 cRNAs joined 
together, to which a small quantity of accessory subunit cRNA (Ascaris unc-38, unc-
29 or unc-63) would be added. Patch-clamp experiments to make single channel 
recordings of the recombinant Ascaris nAChRs would also be very informative, as the 
native Ascaris nAChRs have been characterised on a single-channel level 
(Levandoski et al., 2005). In addition to this, the pharmacology of the heterologously 
expressed putative L- and N-type nAChRs could be further tested using other agonist 
and antagonist compounds; methyridine is an additional agonist which should activate 
the N-subtype, while paraherquamide is an antagonist specific to the L-subtype 
(Martin et al., 2004; Robertson et al., 2002). Unfortunately it was not possible to 
obtain these compounds during the experiments presented here.  
The physiological relevance of different pharmacological subtypes of nAChR in the 
same tissue is unknown, but it is possible that if the receptors possess different 
affinities for the native agonist ACh, then the more sensitive receptors may be 
primarily extrasynaptic, while the less sensitive subtype may be more likely to be 
found clustered at the synapse; this is suggested as the possible physiological 
relevance of mammalian receptors with different agonist affinities by Nelson et al. 
(2003). However, as all single channel measurements of native Ascaris nAChRs have 
to date been from pools of extrasynaptic receptors, it is not known whether this 
interpretation is relevant to the properties of nematode nAChRs. 
In summary, we have demonstrated that the Ascaris homologues of unc-38 and unc-
29 co-express in Xenopus oocytes to form a functional nAChR, which is the first ever 
successful expression of a parasite nAChR. We have also shown that changing the 
receptor stoichiometry also changes the pharmacology, which has not previously been 
described for invertebrate nAChRs. The nAChRs reconstituted here show similar 
pharmacological profiles to the native Ascaris nAChRs described as the N-subtype 
(most sensitive to nicotine and oxantel) and the L-subtype (most sensitive to 
levamisole and pyrantel). The results presented here have important implications for 
the development and management of parasite resistance to cholinergic anthelmintics; 
it has previously been assumed that parasites resistant to levamisole or pyrantel may 
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still be susceptible to oxantel, as different receptor sub-types are involved (Martin et 
al., 2004). If the target receptors of all these cholinergic anthelmintics contain the 
same subunits, a point mutation in one of the subunits which affects drug binding will 
be present in two distinct drug targets, increasing the likelihood of cross-resistance. If 
a more serious loss of function mutation were to occur under anthelmintic selection, 
the converse argument could be made: that cross-resistance is unlikely, as loss of one 
functional subunit may result in the loss of 2 or 3 different receptor subtypes and 
seriously affect cholinergic signalling in the nematode. However, McCarthy and 
colleagues have demonstrated that in hookworms, unc-38, unc-29 and unc-63 are all 
expressed at lower levels in pyrantel resistant populations, and this may be partially 
compensated for by the upregulation of another nAChR subunit, acr-19 (Kopp et al., 
2008). If a similar resistance mechanism was to occur in Ascaris suum, and an 
uncharacterised subunit could take over the role of cholinergic signalling at the 
neuromuscular junction, then cross-resistance to levamisole, pyrantel and oxantel may 
still become a problem. 
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Chapter 7: Conclusions 
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The aim of the work presented here was to interpret the described pharmacology of 
the native neuromuscular nAChRs of Ascaris suum in terms of the underlying 
molecular biology, in particular the levamisole-sensitive nAChR which is the target of 
the cholinergic anthelmintic drugs levamisole and pyrantel. Prior to the start of this 
work, such investigations had previously been confined to the model nematode 
C.elegans, though during the course of the work presented here more recent studies 
emerged associating altered expression levels of nAChR subunits with drug resistance 
in the parasitic hookworm Ancylostoma caninum (Fleming et al.1997, Culetto et al. 
2004, Kopp et al 2008). However, Ancylostoma is closely related to C.elegans, and no 
other research group has to date addressed the role of specific nAChR subunits in 
levamisole sensitivity and resistance in other nematode clades. 
We have shown using a bioinformatics approach that nematodes of clade I and clade 
III have surprisingly small nAChR gene families compared to the clade V nematode 
C.elegans, a finding which could potentially simplify the task of assigning functional 
and pharmacological significance to the nAChR subunits from these parasites. We 
found that sequences encoding 3 proposed components of the levamisole-sensitive 
nAChR from C. elegans, unc-38, unc-29 and unc-63, are well conserved between 
nematodes of different clades. This provides a good basis for more directed studies on 
the role of these nAChR subunits in levamisole sensitivity in parasitic nematodes 
from clades I and III, and this work may also allow potential targets to be selected for 
the design of broad spectrum anthelmintics which will be effective against nematode 
parasites from all clades. 
We have successfully cloned full-length sequences of unc-38 and unc-29 from the 
clade III parasite of pigs Ascaris suum, and partial sequence of unc-63. The reasons 
for failing to amplify a full-length sequence of unc-63 from Ascaris suum could not be 
satisfactorily resolved during the course of the work presented here, though real-time 
PCR experiments suggest that unc-63 is expressed at lower levels than unc-38 and 
unc-29 in this nematode. It is expected that the sequencing of the Ascaris suum 
genome, which is currently underway, will in future allow this matter to be explained. 
The sequences obtained during the course of this work will provide a useful resource 
for comparing against sequences from any levamisole or pyrantel resistant Ascaris 
isolates as a screen for potential resistance mutations. In addition to this, the ability to 
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detect these nAChR subunit sequences by real-time PCR will allow any changes in 
their expression levels in drug resistant Ascaris to be assessed, in a similar manner to 
the work performed by Kopp et al., 2008. 
In addition to the amplification of sequence encoding these proposed components of 
the levamisole-sensitive nAChR, we have amplified a full-length sequence encoding a 
novel, putatively parasite-specific nAChR subunit not present in C.elegans, which has 
been assigned the name acr-26. Work currently being carried out by Hayley Bennett 
in our laboratory will help to evaluate the potential of this novel receptor as a new 
anthelmintic target. 
Heterologous expression of Ascaris suum UNC-38 and UNC-29 in oocytes from 
Xenopus laevis produced functional nAChRs which were subject to two-electrode 
voltage clamp electrophysiology to elucidate their pharmacology. It was perhaps 
surprising that just two nAChR subunits would express robustly to produce functional 
levamisole-sensitive receptors, as UNC-63 is clearly implicated in levamisole 
sensitivity in other nematode species (Culetto et al., 2004, Kopp et al., 2008). 
However, this highlights once again the differences which can be found between 
nematodes of different clades, and cautions against the assumption that C. elegans is a 
valid model for phylogenetically distinct parasitic nematodes. Variations in the 
responses recorded from oocytes injected with equimolar concentrations of unc-
38:unc-29 RNA, along with an awareness of work performed using the mammalian 
α4β2 nAChR, prompted additional experiments to be performed where the receptors 
produced were deliberately driven to form different stoichiometries using different 
ratios of unc-38:unc-29 RNA (Moroni et al. 2006). The receptors generated showed a 
strong resemblance to two of the native Ascaris nAChRs: a greater proportion of unc-
38 (presumably giving a 3:2 UNC-38:UNC-29 stoichiometry) produced  receptors 
most sensitive to nicotine and oxantel, matching the N-subtype described from 
Ascaris suum muscle cells, whereas a greater proportion of unc-29 (presumably 
giving the alternative 2:3 UNC-38:UNC-29 stoichiometry) produced receptors most 
sensitive to levamisole and pyrantel, characteristic of the native L-subtype from 
Ascaris suum (Martin et al., 2003; Martin et al., 2004). This is the first time that the 
phenomenon of alternative stoichiometries displaying different pharmacology has 
been described for an invertebrate nAChR, and may explain how sufficient signalling 
complexity can be generated by nematodes with a very small nAChR subunit gene 
family. We may also speculate that addition of unc-63 to give a 2:2:1 UNC-38:UNC-
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29:UNC-63 stoichiometry would produce the third pharmacological nAChR described 
from Ascaris suum, the B-subtype, defined by bephenium sensitivity (Qian et al., 
2006). Future work to confirm this hypothesis would require obtaining additional 
agonist or antagonist compounds which are reported to be specific for the three 
different pharmacological subtypes, such as the agonists methyridine and bephenium, 
and the antagonists paraherquamide and deoxyparaherquamide (Martin et al., 2003; 
Robertson et al., 2002). It would also be useful to make concatamer constructs of unc-
38 and unc-29 where the sequences and resulting subunit proteins are joined together, 
in order to fix the stoichiometry of the receptors and obtain pure populations of our 
putative N- and L- subtypes (Ericksen & Boileau, 2007). In the absence of a full 
length cDNA sequence from Ascaris suum, it may be possible to co-express the 
Ascaris unc-38 and unc-29 with the unc-63 homologue from another nematode 
species to investigate whether this forms the putative B-subtype. unc-63 sequences are 
already available from Ancylostoma caninum (Kopp et al., 2008) and Haemonchus 
contortus (Thomas Walsh, unpublished); and the bioinformatics work presented here 
has already found unc-63 sequences in silico for Brugia malayi and Trichinella 
spiralis, which should theoretically make these cDNAs easy to amplify if parasite 
material for these species could be obtained by our laboratory. It would also be 
interesting to attempt expression of other parasite nAChRs subunits, in order to 
determine whether their pharmacology and subunit composition resembles that of 
Ascaris nAChRs, or is more similar to that of C. elegans. 
In conclusion, the work presented here describes the first study to address the 
molecular biology underlying cholinergic anthelmintic sensitivity in a clade III 
nematode, and also describes the first functional expression of a nAChR from any 
parasite. This provides a sound basis for future work to be undertaken to assess the 
potential of novel anthelmintics targeting nematode nAChRs in an in vitro expression 
system, and also provides a platform from which the effect of potential resistance 
mutations in nematode nAChRs can be effectively evaluated. 
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Appendix i: Primers 
 
 
SL1  
GGTTTAATTACCCAAGTTTGAG 
 
ANCHOR 
(from Boehringer-Mannhein RACE kit) 
GACCACGCGTATCGATGTCGAC 
 
Ascaris suum unc-38 homologue 
 
S1 fw GTCGCGCTTACCGTTTTCTTCC 
S2 rv CCATCGCCACATATTTCCAGTCTT 
 
5’ RACE (rv primers used with SL1 fw primers) 
S72 TAAAGCACGCTGACACCACC 
S73 ATAGCACAATATCGGGCACC 
 
Full Length 
S84 fw CTGCATTTATTAAGATGTTTGG 
S85 rv ATGTAAATTATTGAGTGACTGG 
  
Ascaris suum ASC19452_1 (acr-26) 
 
S11 fw TCAAATTCACCCGACACAACATA 
S10 fw CGGCAATACGAGAAGGCAGTG 
S12 rv AACAACGCAGACGATTACACG 
S9  rv GAACGATGTCGGGCAACCAGAT 
 
3’ RACE (fw primers used with rv anchor primer) 
3’EST1 TTATCATGGATTTCAAGTGG 
3’EST2 TAATTATGTTGTGTCGGGTG 
 
5’ RACE (rv primers used with fw SL1 primer 
5’EST3 AACGTTTATCGTCAACACCTG 
5’EST2 TCGTCATCGTCATTCCAAGC 
5’EST1 TTATCATGGATTTCAAGT 
 
Full length 
NewESTall fw ATGATGGCAACTCGTCGG 
NewESTall rv TTAATGCAGACCATATAAAGAC 
 
 
 
 
 
 
 
 138
 
 
Ascaris suum unc-29 
 
Degenerate primers used initially 
S55 fw ATCAA(CT)GT(AGCT)GA(CT)GA(AG)AA(AG)GA(CT)CA 
S56 fw TGGAC(AGCT)TA(CT)AA(CT)GA(AG)AA(AG)GA(CT)CA 
S57 rv AT(CT)TC(AG)TT(CT)TC(AG)TT(AG)TA(AGCT)GTCCA 
S58 rv CAG(AGCT)GC(AGCT)AC(AG)TA(CT)TTCCA(AG)TC(AG)TC 
 
5’ RACE 
S57 rv AT(CT)TC(AG)TT(CT)TC(AG)TT(AG)TA(AGCT)GTCCA 
 
3’ RACE 
S65 fw GCACTAAGAGCTATTGACGCG 
S66 fw CATCACTGATCATCTCAAGCAGG 
S67 fw CGAGACGACTGGAAATACATTGC 
 
Full Length 
S82 fw CACTGAGGGCAGTTATGCACC 
S83 rv CAGTGTGGGCGAGATATTAGATC 
 
Ascaris suum unc-63 homologue 
 
Degenerate primers used initially  
S52 fw ATGTG(CT)CA(AG)AT(ATC)GA(CT)GT(ATCG)GA(AG)T 
S53 rv A(AG)(AGT)AT(AG)TCCCA(TC)TCNAC 
 
5’ RACE (nested reamplification) 
new5’63a CGACCGTGCCATTCGACGACA 
new5’63b GACCAAGAACAGTCTCCAAT 
 
Specific Primers for N-terminal  
As63fw AGGATGCCGTGCTTACGCAT 
As63rv TCATGGCGCTTCCCTGGCA 
 
 
 
 
Primers with restriction sites for sub-cloning 
 
For pT7TS: 
unc38 BglII fw AGATCTGTTATGTCCGACGTCGCATGCTC 
unc38 SpeI rv ACTAGTTTGAGTGACTGGAGTCGAG 
unc29 BglII fw AGATCTATGCACCTGCCGTCACC 
unc29 SpeI rv ACTAGTTTAGATTTCTCCTCCATT 
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Real-time PCR primers 
beta-tubulin fw AACTGCAGTCTGTGACATTCCG 
beta-tubulin rv TGTGAATTCCATCTCGTCCATTCC 
RT unc38 fw GTCTCTTAGAAGCATTGCTATGGCT 
RT unc38 rv GGACATAAAGCACGCTGACACCA 
RT unc29 fw CCTCATCATCGTCTACTATGTGCT 
RT unc29 rv CCACCCTGATGTTCTGAATCT 
RT unc63 fw GTGGATGGTATTGTCCCTGCAGCT 
RT unc63 rv GTCCGTCCAACTATGTTGCAGCCA 
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Appendix ii: Abbreviations 
 
AAD   aminoacetonitrile derivative 
ACh    acetylcholine  
Ampr    ampicillin resistance 
ATP    adenosine5'-triphosphate 
ARS    Ascaris ringer solution 
BSA   bovine serum albumin 
CPG   controlled pore glass 
cDNA    complementary deoxyribonucleic acid 
DEPC   diethyl pyrocarbonate 
DTT    dithiothreitol 
EDTA    ethylenediamine tetra acetic acid 
ELISA   enzyme linked immunoabsorbant assay 
EST    expressed sequence tag 
FBS  fetal bovine serum 
FITC  fluorescein isothiocyanate 
GABA  γ-aminobutyric acid 
GluCl  glutamate-gated chloride channel 
HRP    horseradish peroxidase 
IgG    immunoglobulin G 
IPTG    isopropylthio-β-D galactoside 
LB    luria broth 
LGIC    ligand-gated ion channel 
nAChR     nicotinic acetylcholine receptor 
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NMJ  neuromuscular junction 
dNTPs  deoxynucleoside 5'-phosphates 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
RACE    rapid amplification of cDNA ends 
cRNA    capped RNA 
RT    reverse transcriptase 
SOS  standard oocyte saline 
SL1    splice leader 1 
TBE    tris-borate-EDTA buffer 
TM  transmembrane domain 
TMB    tetramethyl Benzidine 
Tris-HCl   tris (hydroxymethyl) methylamine hydrochloride 
UTR   untranslated region 
X-gal    5-bromo-4-chloro-3-indoyl-β-D-galactoside 
 
 
 
 142
